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ABSTRACT 
 The objectives of this work were to study human and bovine brucellosis 
in Kuku Dairy Co-operative Scheme, Khartoum State, Sudan.  And to isolate 
the causative agent and determination of their susceptibility patterns to some 
chemotherapeutic agents and to identify risk factors associated with the 
infection as well.  
 The study provided information about the epidemiology of the disease 
among both animal and human subjects in the study area. Epidemiological 
data were obtained from primary and secondary sources. This was performed 
by conducting two brucellosis field surveys for both humans and cattle. 
Personal communications with experts, meetings with farmers were also used 
as primary sources for data collection. While secondary ones used were 
textbooks, publications and the internet. 
 Human brucellosis survey was carried out in the period from June to 
September 2004.  One hundred and seventy six volunteer participants were 
enrolled in the study, mainly those who were working in close contact with 
animals. The diagnosis of human brucellosis was based on clinical 
examination and serological tests. Those were Rapid Slide Test (RST), Rose 
Bengal Plate Test (RBPT), Competitive Enzyme Linked Immunosorbent 
Assay (cELISA) and Tube Agglutination Test (TAT). The later test is 
practiced routinely for the diagnosis of human brucellosis in the Sudan, but in 
our study was used for titration only. 
 Survey for bovine brucellosis was carried out in the period from January 
to June 2005. Cattle examined were selected randomly from dairy farms 
"holdings" (which represented the primary statistical units). Then the individual 
animals (which represented the secondary statistical units) “i.e. all adults cows” 
were identified and sampled. According to Robinson, (2003) the size of the 
primary statistical units was calculated as 30.1 units, with α =0.05 and desired 
accuracy of 10. The number of animals examined was 566 cows. Blood for 
serum samples, milk, synovial fluids, vaginal swabs and tissues from retained 
placentas were collected for culture.               Diagnosis of bovine brucellosis 
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was based on isolation of brucellae and serological examinations (i.e. RBPT, 
cELISA and Milk Ring Test "MRT").   
 Human brucellosis prevalence rate was found be 16.5%, 15.9 %, 
14.8%, and 11.4% based on RBPT, RST, TAT and cELISA, respectively. Four 
patients (2.3%) out of the total human subjects investigated were found to 
have active disease.  
 Factors associated with infection such as consumption of raw milk 
(92.6% of the study population) and exposure to contaminated materials 
(89.8% of the study population) were found to be the most significant risk 
factors.  
 Bovine brucellosis prevalence rate among selected farms  was found to 
be 93.3% based on RBPT and 90% based on cELISA. While the prevalence 
among individual animals investigated was found to be 32.7%, 27.4%, 28.8 % 
and 1.8% based on RBPT, cELISA, MRT and isolation of brucellae, 
respectively. The study confirmed that the Kuku Dairy Co-operative Scheme 
area was endemic with brucellosis. To strains of Brucella abortus biovar 1 and 
eight strains of Brucella abortus biovar 6 were isolated, and their 
antimicrobial susceptibility patterns to some chemotherapeutic agents were 
determined. And accordingly; two strains of B. abortus biovar 6 were found 
resistant to Rifampicin. 
 The study recommends control of the disease in animals initially by 
whole herd vaccination and adoption of test and slaughter policy thereafter for 
eradication purposes. In addition, education of people at high risk is of 
paramount importance. Furthermore, comprehensive studies at national are 
also recommended.  
 
 
 
 
 
 
 
  
 sisollecurb fo ecnelaverP
  
   ﺑﺴﻢ اﷲ اﻟﺮﺣﻤﻦ اﻟﺮﺣﻴﻢ            
  ﺍﻟﺨﻼﺼـــــــﺔ
 ﺔ ﻭﻻﻴ  ـ،ﻜﻭﻜﻭﺒﻤﺸﺭﻭﻉ ﺃﻟﺒﺎﻥ ﻭﺍﻷﺒﻘﺎﺭ   ﺍﻻﻨﺴﺎﻥ  ﻤﺭﺽ ﺒﺭﻭﺴﻴﻼ ﺩﺭﺍﺴﺔ  ﺍﻟﻲ  ﺍﻟﺒﺤﺙ ﻫﺩﻑ ﻫﺫﺍ  
 ﺘﺤﺩﻴﺩ ﻋﻭﺍﻤل ﺒﻌﺽ ﺍﻻﺩﻭﻴﺔ ﻭ ل ﺍﻟﻤﻴﻜﺭﻭﺏ ﺍﻟﻤﺴﺒﺏ ﻭﺘﺤﺩﻴﺩ ﻨﻤﻁ ﺤﺴﺎﺴﻴﺘﻪ ﻟ ﻋﺯ ﻤﻊ ﺍﻟﺴﻭﺩﺍﻥ-ﺍﻟﺨﺭﻁﻭﻡ
  .ﺍﻟﻤﺨﺎﻁﺭﺓ ﺍﻟﻤﺭﺘﺒﻁﺔ ﺒﺎﻹﺼﺎﺒﺔ ﺒﺎﻟﻤﺭﺽ
ﺘﻭﻓﺭ ﻫﺫﻩ ﺍﻟﺩﺭﺍﺴﺔ ﻤﻌﻠﻭﻤﺎﺕ  ﻋﻥ ﻭﺒﺎﺌﻴﺔ ﺍﻟﻤﺭﺽ ﺒﻴﻥ ﻗﻁﻌﺎﻥ ﺍﻷﺒﻘﺎﺭ ﻭ ﺍﻟﻤﺠﻤﻭﻋـﺔ ﺍﻟﺒـﺸﺭﻴﺔ   
. ﺔ ﻭﺍﻟﺜﺎﻨﻭﻴـﺔ  ﻤﻥ ﻤﺼﺎﺩﺭﻫﺎ ﺍﻷﻭﻟﻴ  ـﻴﻬﺎﺘﻡ ﺍﻟﺤﺼﻭل ﻋﻠ  ﺍﻟﺨﺎﺼﺔ ﺒﻭﺒﺎﺌﻴﺔ ﺍﻟﻤﺭﺽ ﺍﻟﺒﻴﺎﻨﺎﺕ. ﺒﻬﺫﻩ ﺍﻟﻤﻨﻁﻘﺔ 
ﻴﻀﺎ ﺘـﻡ ﺍﺴـﺘﺨﺩﺍﻡ ﺃﺴـﻠﻭﺏ ﺃ.  ﺒﺭﻭﺴﻴﻼ ﺍﻷﺒﻘﺎﺭ ﻭﺴﻴﻼ ﺍﻹﻨﺴﺎﻥﻭﻋﻥ ﺒﺭ ﺈﺠﺭﺍﺀ ﻤﺴﺤﻴﻥ ﺤﻘﻠﻴﻴﻥﻭﺫﻟﻙ ﺒ
 ﺍﻟﺒﻴﺎﻨﺎﺕ ﺍﻟﺜﺎﻨﻭﻴﺔ ﺠﻤﻌﺕ ﻤﻥ ﻤﺨﺘﻠـﻑ .ﺍﻟﻤﻘﺎﺒﻠﺔ ﺍﻟﺸﺨﺼﻴﺔ ﻤﻊ ﺍﻟﻤﻨﺘﺠﻴﻥ ﻭ ﺍﻟﺨﺒﺭﺍﺀ ﻟﺠﻤﻊ ﺍﻟﺒﻴﺎﻨﺎﺕ ﺍﻷﻭﻟﻴﺔ 
  .ﺍﻟﻤﺭﺍﺠﻊ ﻭﺍﻹﺼﺩﺍﺭﺍﺕ ﻭﺸﺒﻜﺔ ﺍﻹﻨﺘﺭﻨﺕ
 ﻡ ﺤﻴـﺙ ﺘـﻡ ﺍﺨﺘﻴـﺎﺭ 4002 ﺇﻟﻰ ﺴﺒﺘﻤﺒﺭ ﻭﺍﻟﻔﺘﺭﺓ ﻤﻥ ﻴﻭﻨﻴ ﺒﺭﻭﺴﻴﻼ ﺍﻹﻨﺴﺎﻥ ﺃﺠﺭﻱ ﻓﻲ ﻤﺴﺢ   
ﻓﻲ ﺍﻟﻤﺸﺎﺭﻜﺔ ﻓﻲ ﻫﺫﻩ ﺍﻟﺩﺭﺍﺴﺔ، ﻭﻗـﺩ ﺸـﻤﻠﺕ ﺍﻟﻤﺘﺒﺭﻋﻴﻥ ﺍﻟﺫﻴﻥ ﺸﺎﺭﻜﻭﺍ ﻓﻲ ﺍﻟﺩﺭﺍﺴﺔ ﺒﻨﺎﺀﺍﹰ ﻋﻠﻰ ﺭﻏﺒﺘﻬﻡ 
  ﺒﺭﻭﺴـﻴﻼ ﺍﻹﻨـﺴﺎﻥ ﺘـﺸﺨﻴﺹ ﺘﻡ . ﻤﻥ ﺍﻟﻤﺤﺘﻜﻴﻥ ﺍﺤﺘﻜﺎﻙ ﻤﺒﺎﺸﺭ ﻤﻊ ﺍﻟﺤﻴﻭﺍﻥ ﻤﺘﻁﻭﻋﺎ  671 ﺍﻟﺩﺭﺍﺴﺔ
،ﺍﺨﺘﺒﺎﺭ  TBRﺍﺨﺘﺒﺎﺭ ﺍﻟﺭﻭﺯ ﺒﻨﻘﺎل ٌ: ﻴﺔ ﺍﻵﺘﻴﺔ ﻤﺼﻠﺍﻟ ﺍﺕ ﺍﻟﺴﺭﻴﺭﻱ ﻟﻠﻤﺭﻀﻰ ﻭﺍﻻﺨﺘﺒﺎﺭ ﺍﻟﻔﺤﺹﺒﻭﺍﺴﻁﺔ 
 ﻭﻫـﺫﺍ TAT ﻭ ﺍﺨﺘﺒﺎﺭ ﺃﻨﺒﻭﺏ ﺍﻟـﺘﻼﺯﻥ ASILEc، ﺍﺨﺘﺒﺎﺭ ﺍﻻﻟﻴﺯﺍ ﺍﻟﺘﻨﺎﻓﺴﻴﺔ  TSRﺍﻟﺸﺭﻴﺤﺔ ﺍﻟﺴﺭﻴﻊ 
  . ﻓﻲ ﺍﻟﺴﻭﺩﺍﻥﺴﺘﺨﺩﻡ ﺭﻭﺘﻴﻨﻴﺎ ﻓﻲ ﺘﺸﺨﻴﺹ ﺍﻟﺤﻤﻰ ﺍﻟﻤﺎﻟﻁﻴﺔﺍﻷﺨﻴﺭ ﻴ
ﺼﻤﻤﺕ ﺍﻟﺩﺭﺍﺴﺔ ﻋﻠﻰ .  ﻡ 5002ﻤﺴﺢ ﺒﺭﻭﺴﻴﻼ ﺍﻷﺒﻘﺎﺭ ﺘﻡ ﻓﻲ ﺍﻟﻔﺘﺭﺓ  ﻤﺎ ﺒﻴﻥ ﻴﻨﺎﻴﺭ ﺇﻟﻲ ﻴﻭﻨﻴﻭ   
،  ﻋﺸﻭﺍﺌﻴﺎ "ﺍﻟﻭﺤﺩﺍﺕ ﺍﻹﺤﺼﺎﺌﻴﺔ ﺍﻷﻭﻟﻴﺔ  "(ﺍﻟﺤﻴﺎﺯﺍﺕ) ﺍﻟﻤﺯﺍﺭﻉ  ﺍﻟﻤﺭﺤﻠﺔ ﺍﻷﻭﻟﻰ ﺘﻡ ﺍﺨﺘﻴﺎﺭ ﻓﻲ: ﻤﺭﺤﻠﺘﻴﻥ
 ﻋﻠﻰ ﺇﻋﺘﻤﺎﺩﺍ. ( ﺍﻟﺜﺎﻨﻭﻴﺔﺍﻟﻭﺤﺩﺍﺕ ﺍﻹﺤﺼﺎﺌﻴﺔ)   ﻜل ﺍﻷﺒﻘﺎﺭ ﺍﻟﺒﺎﻟﻐﺔﺫ ﻋﻴﻨﺎﺕ ﻤﻥ ﺍﻟﻤﺭﺤﻠﺔ ﺍﻟﺜﺎﻨﻴﺔ ﺘﻡ ﺍﺨﻭﻓﻲ
 ﺒﻴﻨﻤﺎ  "(01" ﻭ ﺩﻗﺔ α = 50.0 ) ﺤﻴﺎﺯﺓ03ﺨﺘﺎﺭﺓ ﺍﻟﻤ ﺒﻠﻎ ﻋﺩﺩ ﺍﻟﺤﻴﺎﺯﺍﺕ   ﻓﻘﺩ )3002( ,nosniboR 
ﺠﻤﻌﺕ ﻋﻴﻨﺎﺕ ﻤﻥ ﺍﻟﺩﻡ ﻟﻠﺤﺼﻭل ﻋﻠﻰ ﺍﻟﺴﻴﺭﻡ ﺒﺎﻹﻀـﺎﻓﺔ .  ﺒﻘﺭﺓ 665  ﺍﻟﺘﻲ ﺘﻡ ﻓﺤﺼﻬﺎ ﺒﻠﻎ ﻋﺩﺩ ﺍﻷﺒﻘﺎﺭ 
ﺼل، ﻭﻤﺴﺤﺎﺕ ﻤﻥ ﺍﻟﻤﻬﺒل ﻭﺃﺠـﺯﺍﺀ ﻨـﺴﻴﺠﻴﺔ ﻤـﻥ ﺎﻟﻤﻔﻤﻥ ﺍ ﻟﻌﻴﻨﺎﺕ ﺃﺨﺭﻯ ﻤﺜل ﺍﻟﺒﻥ، ﺍﻟﺴﺎﺌل ﺍﻟﺯﻻﻟﻲ 
ﺘﺸﺨﻴﺹ ﺒﺎﻟﻨﺴﺒﺔ ﻟﺒﺭﻭﺴﻴﻼ ﺍﻷﺒﻘـﺎﺭ ﻋﻠـﻲ ﺯﺭﺍﻋـﺔ  ﺍﻋﺘﻤﺩ ﺍﻟ .ﻋﺯل ﺍﻟﺒﻜﺘﻴﺭﻴﺎ  ﺯﺭﺍﻋﺔ ﻭ ﺍﻟﻤﺸﻴﻤﺔ ﺒﻐﺭﺽ 
   .TRM  ﺍﺨﺘﺒﺎﺭ ﺤﻠﻘﺔ ﺍﻟﻠﺒﻥ  ﻭASILEc ﻭ TPBRﺍﻻﺨﺘﺒﺎﺭﺍﺕ ﺍﻟﻤﺼﻠﻴﺔ ﻤﺜل ﻭ ﺍﻟﺒﻜﺘﻴﺭﻴﺎ 
 %4.11 ﻭ% 8.41،  %9.51،  %5.61ﺒﻠﻎ ﻤﻌﺩل ﺍﻨﺘﺸﺎﺭ ﺍﻟﻤﺭﺽ ﺒﺎﻟﻨﺴﺒﺔ ﻟﺒﺭﻭﺴﻴﻼ ﺍﻹﻨﺴﺎﻥ   
 ﻋﻠـﻰ ﺍﹰﺒﻨﺎﺀ % 3.2ﻤﻌﺩل ﺒﻴﻨﻤﺎ ﺒﻠﻎ ﺍﻟ .ﻋﻠﻰ ﺍﻟﺘﻭﺍﻟﻲ ، ASILEc ﻭ TAT ،TSR ، TBRﺒﻨﺎﺀﺍﹰ ﻋﻠﻰ 
  .ﺍﻟﺤﻘﻴﻘﻴﺔﺍﻹﺼﺎﺒﺔ 
 sisollecurb fo ecnelaverP
  
ﻌـﺭﺽ ﺍﻟﺘ ﻭ(ﻤﻤﻥ ﺸﻤﻠﻬﻡ ﺍﻟﺒﺤـﺙ % )6.29 ﺃﺘﻀﺢ ﻤﻥ ﺍﻟﺩﺭﺍﺴﺔ ﺃﻥ ﺸﺭﺏ ﺍﻟﻠﺒﻥ ﻏﻴﺭ ﺍﻟﻤﻐﻠﻲ  
ﺘﻲ ﻗﺩ ﺘﺘﺴﺒﺏ ﻫﻲ ﻤﻥ ﺃﻜﺜﺭ ﻋﻭﺍﻤل ﺍﻟﻤﺨﺎﻁﺭﺓ ﺍﻟ (ﻤﻤﻥ ﺸﻤﻠﻬﻡ ﺍﻟﺒﺤﺙ%  8.98 )ﻟﻤﻭﺍﺩ ﻤﻠﻭﺜﺔ ﺒﺎﻻﺒﺭﻭﺴﻴﻼ
  .ﻓﻲ ﺤﺩﻭﺙ ﺍﻹﺼﺎﺒﺔ ﺒﺒﻜﺘﻴﺭﻴﺎ ﺍﻟﻴﺭﻭﺴﻴﻼ
 3.39 ﺒﻴﻥ ﺍﻟﻤﺯﺍﺭﻉ ﺍﻟﺘﻲ ﺸﻤﻠﻬﺎ ﺍﻟﺒﺤﺙ  ﺒﻠﻎ ﻤﻌﺩل ﺍﻨﺘﺸﺎﺭ ﺍﻟﻤﺭﺽ  ﻓﻘﺩ ﻷﺒﻘﺎﺭﺍﻟﺒﺭﻭﺴﻴﻼ ﺒﺎﻟﻨﺴﺒﺔ   
 % 7.23 ﻤﻌﺩل ﺍﻻﻨﺘﺸﺎﺭ ﺒﻴﻥ ﺍﻷﺒﻘـﺎﺭ ﺒﻴﻨﻤﺎ ﺒﻠﻎ  ASILEc   ﺒﻨﺎﺀﺍ ﻋﻠﻰ%09ﻭ  TBRﺒﻨﺎﺀﺍ ﻋﻠﻰ  % 
  ﻗﺩ .ﻭﺴﻴﻼ ﺍﻟﺒﺭ ﻋﺯلﺒﻨﺎﺀﺍ ﻋﻠﻰ ﻨﺘﺎﺌﺞ  % 8.1 ﻭ ASILEc ﺒﻨﺎﺀﺍ ﻋﻠﻰ %4.72 ﻭ TPBRﺒﻨﺎﺀﺍ ﻋﻠﻰ 
 ﻤﻴﻜـﺭﻭﺏ  ﻤﻥ ﺤﻴﺙ ﺘﻡ ﻋﺯل ﻋﺘﺭﺘﻴﻥ .  ﺃﻟﺒﺎﻥ ﻜﻭﻜﻭ ﻤﻭﺒﻭﺀﺓ ﺒﺎﻟﻤﺭﺽ ﻉﻘﺔ ﻤﺸﺭﻭ ﺃﻜﺩﺕ ﺍﻟﺩﺭﺍﺴﺔ ﺃﻥ ﻤﻨﻁ 
.  ﻤﻥ ﺍﻷﺒﻘﺎﺭ ﻓﻲ ﻫﺫﻩ ﺍﻟﻤﻨﻁﻘـﺔ 6 ﺍﻟﻨﻭﻉ ﺍﻟﺤﻴﻭﻱ  ﻤﻥ  ﻋﺘﺭﺍﺕ 8 ﻭ 1ﻟﻨﻭﻉ ﺍﻟﺤﻴﻭﻱ ﺍﺍﻟﺒﺭﻭﺴﻴﻼ ﺍﻟﻤﺠﻬﻀﺔ 
 6، ﻭﻗﺩ ﻭﺠﺩ ﺃﻥ ﻋﺘﺭﺘﻴﻥ ﻤﻥ ﺍﻟﻨﻭﻉ ﺍﻟﺤﻴﻭﻱ ﺒﻌﺽ ﻤﻀﺎﺩﺍﺕ ﺍﻟﻤﻴﻜﺭﻭﺒﺎﺕ ﺤﺴﺎﺴﻴﺘﻬﺎ ﻟ ﺃﻨﻤﺎﻁ ﻜﻤﺎ ﺘﻡ ﺘﺤﺩﻴﺩ 
  .  ﻤﻘﺎﻭﻤﺔ ﻟﻠﻤﻀﺎﺩ ﺍﻟﺤﻴﻭﻱ ﺍﻟﺭﻴﻔﺎﻤﺒﻴﺴﻴﻥﻟﻠﺒﺭﻭﺴﻴﻼ ﺍﻟﻤﺠﻬﻀﺔ
 ﺍﻟﺤﻴﻭﺍﻥ ﻭﺫﻟﻙ ﺒﺈﺘﺒﺎﻉ ﺴﻴﺎﺴـﺔ  ﺍﻟﺘﻁﻌـﻴﻡ ﺍﻟﻜﻠـﻰ ﻓﻲﻟﺴﻴﻁﺭﺓ ﻋﻠﻰ ﺍﻟﻤﺭﺽ  ﺒﺎ ﺃﻭﺼﺕ ﺍﻟﺩﺭﺍﺴﺔ   
ﻜﻤﺎ ﺃﻭﺼﺕ .  ﺒﻐﺭﺽ ﺍﺴﺘﺌﺼﺎل ﺍﻟﻤﺭﺽ ﻭﺫﺒﺢ ﺍﻟﺤﻴﻭﺍﻨﺎﺕ ﺍﻟﻤﻭﺠﺒﺔ ﺒﻨﻲ ﺴﻴﺎﺴﺔ ﺍﻻﺨﺘﺒﺎﺭ ﺘ ﺜﻡ  ﺃﻭﻻ ﻟﻠﻘﻁﻴﻊ
ﻤـﺎ ﻜ .ﺍﻟﺒﺭﻭﺴﻴﻼﺨﻁﺭ ﺍﻹﺼﺎﺒﺔ ﺒﻤﺭﺽ ﻟ  ﻟﻸﻨﺎﺱ ﺍﻷﻜﺜﺭ ﻋﺭﻀﺔ ﺍﻟﺩﺭﺍﺴﺔ ﺃﻴﻀﺎ ﺒﺘﻨﻔﻴﺫ ﺒﺭﺍﻤﺞ ﺇﺭﺸﺎﺩﻴﺔ 
 ﺘﺸﻤل ﻜل ﺍﻟﻘﻁﺭ ﻟﻤﻌﺭﻓﺔ ﻟﻤﺯﻴﺩ ﻋﻥ ﺩﺭﺍﺴﺎﺕ ﻋﻠﻰ ﻨﻁﺎﻕ ﻭﺍﺴﻊ ﺍﻟ  ﻤﺯﻴﺩ ﻤﻥ ﺇﺠﺭﺍﺀﺘﻭﺼﻲ ﺍﻟﺩﺭﺍﺴﺔ ﺃﻴﻀﺎ 
  .ﻭﺒﺎﺌﻴﺔ ﺍﻟﻤﺭﺽ
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Introduction 
Background  
 Animal and human healths are inextricably linked. People depend on 
animals for nutrition, socio-economic development and companionship. Yet 
animals can transmit many diseases to humans. Diseases transmitted from 
animals to humans are termed zoonoses. Some of them are potentially 
devastating. 
 Brucellosis is an infectious zoonotic disease caused by bacteria of the 
genus Brucella. These bacteria are primarily passed among animals, and they 
cause disease in many different vertebrates. Various Brucella species affect 
sheep, goats, cattle, deer, elk, pigs, dogs, and several other vertebrates. 
Humans become infected by coming in contact with infected animals or animal 
products (mostly raw milk and milk products). The disease in humans can 
cause a range of symptoms that are similar to the flu and may include fever, 
sweats, headaches, back pains, and physical weakness. Severe infections of the 
central nervous systems or lining of the heart may occur. Brucellosis can also 
cause long-lasting or chronic symptoms that include recurrent fevers, joint 
pains, orchitis, meningitis and fatigue (CDC, 2005). In humans, mortality is 
negligible, but the illness can last for several years (Madkour, 2001). In 
animals, brucellosis mainly affects reproduction and fertility, reduces survival 
of newborns, and reduces milk yield but mortality of adult animals is 
insignificant (Sewell and Brocklesby, 1990). Brucellosis not only a zoonotic 
problem but also has an economic significance in most developing countries. 
In many developed countries, the animal disease has been brought under 
control, which has led to subsequent decrease in the number of human cases 
(WHO, 1997).  
 At present there are seven species known. These are: Brucella abortus 
"B. abortus" (cattle are the main reservoir), B. melitensis (sheep & goats), B. 
suis (pigs, hares, rodents and reindeers), B. canis (dogs), B. ovis (sheep), B. 
neotomae (wood rat Neotomae Lepida Thomas). Only four species are known 
to produce infection in Man, these are in decreasing order of importance and 
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virulence: B. melitensis, B. abortus, B. suis and B. canis (Jinkyung and Spliter, 
2003). Currently, two reports indicated that marine mammals Brucella strains 
have a zoonotic potential. In England, a laboratory worker got infected and 
developed clinical brucellosis while handling cultures of a Brucella isolate 
from a seal, (Brew et al., 1999). In April 2003, the first report of community-
acquired human infections with marine mammal-associated Brucella spp. was 
published. The authors described the identification of these strains in two 
patients with neuro-brucellosis and intracerebral granulomas (Sohn et al., 
2003). Sero-conversion and abortion in cattle experimentally infected with 
Brucella spp. isolated from the Pacific harbor seal (Phoca vitulina richardsi) 
has been reported (Rhyan et al., 2001). It has been proposed, based on host 
preference and molecular classification methods, that brucellae isolated from 
such diverse marine mammal species such as seals and dolphins could actually 
comprise at least two new species: Brucella cetaceae "preferentially infecting 
cetaceans" and Brucella pinnipediae "preferentially infecting pinnipeds"  
(Cloeckaert et al., 2001). 
 In all host species brucellae grow intracellulary producing a variable 
bacteraemic phases followed by localization in the tissues of the genital tract 
and in the mammary gland occurs and in humans mainly the reticuloendothelial 
system (Jinkyung and Spliter, 2003). Pathological manifestations as abortion, 
placentitis, endometritis, orchitis, hygromas, epidydimitis, and arthritis are not 
uncommon sequellae of infection with brucellosis in animals (Blood et al., 
1983) 
 Brucellosis is diagnosed either by isolation of Brucella organism or by a 
combination of serological tests and clinical findings consistent with 
brucellosis (Al Sekait, 1999).  Isolation of Brucella organisms is the definite 
means of diagnosis, but in practice it is difficult due to early tissue localization 
and the exacting growth requirements of the organism (Al- Sekait, 1999). 
Conventional tests, such as Rose Bengal Plate Test (RBPT), Rapid Slide Test 
(RST), Tube Agglutination Test (TAT), Complement Fixation Test (CFT), 
have been used in the diagnosis of brucellosis. In addition Enzyme-linked 
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Immuno-sorbent Assay (ELISA) and Polymerase Chain Reaction (PCR) 
techniques have recently being suggested as favourite approaches in the 
diagnosis of brucellosis (Lucero et al., 1999; and Al- Attas et al., 2000).   
 Treatment of bovine brucellosis is not usually undertaken. Nevertheless, 
trials using bovine plasma, sulfadiazine, streptomycin and chlortetracycline 
given parentally, or the latter two as udder infusions, have been unsuccessful in 
eliminating the infection (Blood et al., 1983). However; human brucellosis 
have been successfully treated by a combination of  doxycycline 100 mg PO 
twice daily and rifampicin 600-900 mg/d PO given for 6 weeks or doxycycline 
and streptomycin 1g daily IM for 2-3 wks (Corbel, 1997). 
Justification 
  Brucellosis is a worldwide zoonotic disease (Boschiroli et al., 2001). 
The absence of recent epidemiological data on human and animal brucellosis as 
well as the inexistence of an ongoing control program for the disease 
necessitated the conduction of epidemiological studies that aim at providing 
useful data for further studies and/or intervention policies.  
 Brucellosis was proved to be enzootic in the Sudan, and has been 
reported in many parts of the country (Bennet, 1948; Dafaalla and khan, 1958). 
More recent studies in Khartoum State reported bovine brucellosis prevalence 
of 15.2% (Suliman, 1987). However, the disease in humans has not been well 
documented, and published data on human brucellosis in the Sudan is lacking. 
A survey on human brucellosis was carried out earlier (AL Sharif, 1994) 
showed 10% prevalence rate of the disease among workers of the Omdurman 
City Slaughterhouse, Khartoum State. 
 At present the situation of the disease in Khartoum State is not clear 
since that it was not extensively being studied. However, three of the private 
farms within the Kuku Dairy Co-operative Scheme (the study area) were 
screened by RBPT, found to have a prevalence rate above 50 % among farm 
animals (Al Nour, 2003). These results do not reflect the actual situation of the 
disease in the scheme, but represent a serious indication for brucellosis that 
needs to be investigated. Moreover, animals in the study area represent 60% of 
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the cross bred cattle raised for milk production in the Sudan (Al Mahi, 2003), 
and provide Khartoum state with the highest demand of milk. The Kuku 
Scheme represents a major source of highly productive foreign breeds, from 
where they are sold to other parts of the country. This may be the most serious 
role of the Kuku Scheme in spreading the disease all over the country (Al Mahi, 
2003).  
 The possible existence of drug resistant Brucella strains may become 
evident without being noticed since drug susceptibility testing for brucellae is 
not routinely carried out either in veterinary or medical laboratories. Therefore; 
investigations are required to uncover possible drug resistant Brucella strains.  
Objectives of the study 
General objective 
1- To determine the prevalence rate of human and bovine brucellosis in the 
Kuku  Dairy Co-operatives Scheme, Khartoum North- Sudan. 
2- To determine antimicrobial susceptibility pattern of the prevalent strains of 
 Brucella spp. 
Specific objectives  
1. To determine the level of anti-brucella antibodies among workers of the 
Kuku  Dairy Scheme  
2- To detect the presence of anti-brucella antibodies among cattle raised in the 
Kuku  Dairy Scheme 
3- To isolate the causative organism and to identify it to the genus, species and 
biovar  level using phenotypic and (if possible) genotypic methods. 
4 -  To identify the risk factors for infection with brucellosis among the study 
 population 
5 - To determine the susceptibility of brucella spp. to streptomycin, rifampicin, 
 doxycycline and other antibiotics.  
3. Secondary objectives 
 To establish a valid and reliable data on human and animal brucellosis 
that could be useful for further studies and/or intervention policies. 
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Chapter one 
Literature review 
1.1 Morphology 
 Typically Brucella spp. occur as small gram-negative coccobacilli, but 
coccal and bacillary forms also occur. The cells are short and slender, the axis 
is straight; the ends are rounded; the sides may be parallel or convex outwards. 
In length they vary from about 0.6 µm to 1.5µm, and in breadth from 0.5µm to 
0.7µm. the short forms may appear as oval cocci, or if they are arranged singly, 
in pairs end to end, or in small groups; sometimes short chains of 4-6 members 
may be seen, especially in liquid media. Because of their frequently coccoid 
appearance, their bacillary nature may be in doubt, but it may be noted that 
they are smaller than any of the Gram-negative cocci. Moreover, when 
arranged in pairs, their long diameter is in the same axis as that in which they 
are lying, as distinct from the gram-negative diplococci, whose long axis is 
generally at right angles to that in which they are lying. B. melitensis tends to 
be more coccal in form than B. abortus but this is not consistent enough to be 
of value for identification. The bacillary forms of B. abortus and B. suis are 
most readily apparent when grown on a rich medium, in which individual cells 
may reach 2-3 µm in length. B. melitensis usually remains cocoid and rarely 
exceeds 1µm in length. The organisms stain fairly well with the ordinary dyes. 
They are gram-negative, non acid fast, non-motile and non-sporing. Bipolar 
staining can occur and irregularity in the depth of colour may be seen 
especially in old cultures in which irregular forms appear (Corbel, 1998). 
Brucella cells resist decolorization by dilute solutions of acids and alkalis, an 
advantage that has been utilized in differential staining procedure known as 
Modified Ziehl-Neelsen methods (Stamp et al., 1950). 
 1.2 Cultural properties 
 A part from different carbon dioxide requirement, all members of the 
genus resemble each other closely in cultural properties. Although most strains 
will grow on nutrient agar, growth tends to be slow and colony size small.  
Growth is much improved by the addition of blood, serum and tissue extracts. 
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Liver infusion agar was formerly recommended for the isolation of Brucella  
spp. But has been superseded by more consistent media based on high quality 
peptone preparation, usually tryptic digests of soybeans protein. These will 
support the growth of all but the most fastidious strains. On serum dextrose 
agar or similar medium, most Brucella strains produce raised, convex, circular, 
translucent colonies, 0.5-1mm in diameter, after incubation for 48h at 370C. In 
direct light the colonies of smooth strains show a clear honey colour, but in 
reflected light they have a distinctive bluish-grey translucency. Non smooth 
strains produce colonies of similar size but of much more variable colour and 
consistency. Strains of less fastidious types, especially B. melitensis, B. suis 
will grow on bile-salt media producing small lactose-negative colonies. 
Growth in gelatin is poor and liquefaction is not produced. On blood agar the 
colonial appearance is not distinctive, true haemolysis is not produced but 
greenish brown discoloration develops around the colonies. In static liquid 
culture, maximum turbidity is produced after 7 days or longer. Most strains 
produce a uniform turbidity with a variable deposit. Smooth colonies appear 
small, circular, convex, translucent and grayish-blue with a smooth glistering 
surface. The individual cells are uniformly short rods or cocco-bacilli arranged 
singly. Colonies of rough strains are of much the same size, but are less 
convex, more opaque and have a dull dry yellowish-white granular appearance. 
The individual cells are rather larger than those of smooth form, and occasional 
long slender rods are present (Corbel and Hendry, 1985)  
1.3 Metabolism and biochemical properties 
 All Brucella strains are aerobic and require oxygen for growth. No 
growth occurs under strictly anaerobic conditions. Some strains require 
supplementary carbon dioxide. Although acid from sugars has been 
demonstrated under special conditions, metabolism is essentially oxidative 
(Pikett and Nelson, 1955). Brucella strains are catalase positive and most are 
oxidase positive. They also have superoxide dismutase activity mediated by 2 
distinct enzymes, a manganese superoxide dismutase of typical prokaryote type 
(Sriranganathan et al., 1991), and copper-zinc enzyme (Beck et al., 1990). 
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Energy yielding processes involve the monophosphate pathway and 
tricarboxylic acid cycle (Robertson and McCullough, 1964). Glucose is 
metabolized by most strains but isoerythritol is used preferentially by B. 
abortus, B. melitensis and B. suis. B. ovis shows little activity towards either 
substrates ; its energy source is unknown, but it has been shown to oxidize 
water-soluble components of various ovine tissues very actively (Redwood and 
Corbel, 1983). Most Brucella strains produce nitrate reductase and will reduce 
nitrate to nitrite and also reduce nitrite, especially B. suis Biogroup 1. B. ovis 
and, occasionally, strains of other species, do not reduce nitrate. Hydrogen 
sulphide is produced from sulphur-containing amino acids. Strains of B. 
abortus, B. neotomae and B. suis biogroup 1 produce it in sufficient quantity to 
assist in their identification; the other species produce it in small quantities or 
not at all. Brucella strains do not produce indole from tryptophan. Urease is 
produced by most trains but the activity varies considerably between species 
and even between strains within species. B. canis and B. suis consistently give 
strong urease reaction, producing magenta colour on Christensen's medium 
with 5min. at the other extreme, B. ovis is a weak producer of urease and some 
strains may give negative reaction even after incubation for 7 days. Strains of 
B. abortus, B. melitensis and B. neotomae fall between these extremes and 
usually give positive urease reaction after 1h or more. Nevertheless variation 
occurs between strains and the test is of limited value for species identification 
(Corbel and Hendry, 1985). The oxidative activity of Brucella strains towards 
selected amino acid and carbohydrate substrates varies in a manner which 
correlates closely with other properties used to define the species. Originally, 
manometric methods were used to detect oxidation and although hazardous and 
time-consuming to perform, they are still useful when quantitative studies are 
to be performed. Nevertheless, quantitative variations in activity between 
strains within species can cause confusion (McCullough and Beal, 1951). To 
overcome this problem, Verger and Grayon (1977) established three levels of 
oxidative activity, corresponding to low, medium and high oxygen uptake, 
which they used to produce a metabolic profile for each of the main species. 
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The metabolic activity towards selected substrates can also be determined 
qualitatively by thin layer chromatography (Balke et al., 1977). The patterns of 
oxidative activity characteristic of species are shown in table 1  
1.4 Antigenic structure  
 The smooth Lipopolysaccharide (S-LPS) is the immunodominant 
antigen of the Brucella cell surface and major virulence factor. It has endotoxic 
activity but shows some major differences in activity from enteric endotoxins 
typified by E. coli LPS. For example it is much less toxic for rabbits, chick 
embryos and endotoxin-sensitive mouse strains. It is much more toxic than E. 
coli endotoxin for endotoxin-resistant mouse strains and is effective in 
stimulating interleukin-1 and tumor necrosis factor-α. It is also toxic for 
macrophages and is antigenic for spleen B but not T-lymphocytes.   
Table 1. Oxidative metabolism of species of Brucella. 
 b.melitensis  B.abortus B. suis B. neotomae B.canis  B. ovis 
Amino acids 
L-Alanine 
+ + v* v v v 
L-Aspargine + + v* + - + 
L-Glutamate - + v* + + + 
L-Arginine - - + - + - 
Amino acids B. melitensis B. abortus B. suis B. neotomae B. canis   B. ovis
DL-Citrulline - - + - + - 
L-Lysine - - v* - + - 
DL-Ornithine - - + - + - 
Carbohy-drates  
L-Arabinose 
 
- 
 
+ 
 
v* 
 
+ 
 
v 
 
- 
D-Galactose - + v* + v - 
D-Ribose - + + V + - 
D-Xylose - V - - - - 
D-Glucose + + + + + - 
Isoerythritol + + + + v - 
+, positive; -,negative; v, variation between strains; v*, variation between biogroups of some assistance in 
classification.  Source: Corbel, 1998 
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 Its lipid A does not bind polymyxin B and this does not necessarily 
inhibit its mitogenic or toxic activity. Brucella LPS has an unusual adjuvant 
activity in that it stimulates high level of IgG and IgM antibodies in mice. It’s a 
major protective antigen in mice and other species including cattle (Corbel, 
1998). Various polysaccharides structurally related to Brucella LPS O chain 
have been described. These include ‘native antigen’ or ‘native hapten’. This 
can be extracted from LPS or whole cell. Its association with lipid and protein 
is controversial it is believed to be O chain which has not been incorporated 
into LPS. The rough strain B. melitensis B115 has been shown to synthesize 
smooth O chain which accumulates in the cytoplasm but is not assembled into 
complete LPS nor exported to the cell surface. (Cloeckaert et al., 1992). 
 The outer-membrane proteins include the outer-membrane of groups 1, 
2, and 3, the most quantitatively important of which are the group 2 porins. 
These and other proteins associated with the peptidoglycan fraction of the 
outer membrane have been investigated as candidate protective antigen. In 
general, attempts to demonstrate protection with monoclonal or polyclonal 
antibodies to these have indicated low activity in the absence of antibody to 
smooth LPS (Jacques et al., 1992). However, this does not disprove their role 
in protective immunity as they could still be implicated in relevant cell 
mediated responses (Corbel, 1998). The A and M specific epitopes are actually 
present as minority structures in both R & S (LPS). By means of slide 
agglutination, the A or M antigen predominance of Brucella strains can be 
determined (Wilson and Miles, 1932). This information is useful in classifying 
Brucella smooth nomen species into biogroups. strains that are both A and M 
antigen positive synthesize LPS with O chains that contain both A and M 
structural features in relatively high proportion (Perry and Bundle, 1990).      
1.5 Susceptibility to physical and chemical agents 
 The members of this group exhibit the usual susceptibility of vegetative 
bacteria to heat and disinfectant. In aqueous suspensions of moderate density 
they are destroyed by heating for about 10 min at 600c but in very dense 
suspensions they may survive higher temperature (Swann et al., 1981). In agar 
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cultures kept sealed at 40c they generally survive for at least one month, and 
often longer. If lyophilized, especially in the presence of protecting agent, they 
will survive for decades. Under natural conditions in favorable circumstances, 
B. melitensis may remain viable for 6 days in urine 6 weeks in dust and 10 
weeks in water and soil. In pickled hams from naturally infected pigs, B. suis 
can live for as long as 3 weeks, but it is apparently destroyed by. B .suis may 
live on sacking for 4 weeks and in sterile faeces for 100 days in the dark 
smoking (Hutchings et al., 1951). B. abortus may survive for 7months in 
infected uterine exudates kept at about freezing point. It can also survive in 
bovine urine for 4days, faeces 120 days, aborted fetuses for 75 days and liquid 
manure for up to 2.5 years. In raw milk at room temperature it seems to die out 
fairly rapidly with the production of acid. Acid production also seems to be the 
cause of its rapid death in butter, cheese and yoghurt although variable reports 
exist on its survival in these materials (Bang, 1897).  
 In general, survival in soft, non-acid cheese is much longer than in hard, 
lactic or propionic acid fermented cheese. Pasteurization, whether by holder or 
high temperature short time cycles, kills brucellae in milk. Ultraviolet and γ-
radiation at normal sterilization dosage are rapidly lethal to Brucella provided 
that the organisms are not protected by the suspending medium. Ethanol, 
isopropanol, iodophors, phenols, hypochlorite, ethylene oxide, and 
formaldehyde (either gaseous or as aqueous formalin) are effective 
disinfectants for Brucella under appropriate conditions; they are killed by 1.0 
% phenol in 15 min. xylene and calcium Cyanamid have been recommended 
for killing Brucella in manure but prolonged contact times are required 
(FAO/WHO, 1986) 
1.6 Susceptibility to antimicrobial agents: 
 Good intracellular penetration is essential for in vivo activity against 
Brucella and thus there is limited correlation between in vitro performance and 
therapeutic efficacy. β-lactam antibiotics show limited activity against 
brucellae (Hall and Manion, 1970). Some strains are inhibited by 
benzylpenicillin, ampicillin and amoxycillin. Most strains are resistant to 
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methicillin, nafcillin, ticarcillin and piperacillin. Similarly, first and second 
generation cephalosporins show limited activity against Brucella but some 
third generation cephalosporins such as cefotaxime, ceftizoxime, and 
cetfriaxone have MICs in the range 0.25-2 mg l-1 , (Palenque et al., 1986). 
Latamoxef is also active and has been used therapeutically, alone or in 
combination with rifampicin (Tosi and Nelson, 1982). The MIC for 
chloramphenicol is in the range 2-3 mg l-1 for most strains. Sensitivity to 
macrolides is variable. With the exception of B. abortus biogroup 2 and B. 
ovis, most strains are resistant to erythromycin, with MIC90 ≥16 mg l-1. 
Sensitivity to dirithromycin and axithromycin show 2-8 fold greater activity 
(Garcia-Rodriguez et al., 1993). Most Brucella strains are inhibited by 
streptomycin, gentamicin, kanamycin, tobramycin and amikacin at 
concentrations of 1-4 mg l-, (Mortensen et al., 1986). Streptomycin augments 
the activity of tetracycline in infected cell cultures and this is borne out by 
therapeutic experience (Richardson and Holt, 1962; and Colmenero et al., 
1989). Sensitivity to tetracycline is universal, with MICs in regions of 0.1mg l-
1 (Hall and Manion, 1970). Brucella strains are also highly sensitive to 
rifampicin; the MICs for rifampicin are in the range 0.1-2mg l-1 (Hall and 
Manion, 1970 and Corbel, 1976a). Single step resistance develops rapidly in 
vitro (Corbel, 1976a) and has also been observed during the course of therapy 
(Rautlin de la Roy et al., 1986). Brucella strains are generally resistant to 
nalidixic acid but show in vitro sensitivity to the floroquinolones. The MICs 
for ciprofloxacin are in the range 0.5-1mg l-1 but therapeutic results have been 
disappointing (Bosch et al., 1986). Sensitivity to cotrimoxazole is borderline 
with MIC90 being just within the breakpoint. This is consistent with the high 
relapse rate observed with this drug (Garcia-Rodriguez et al., 1993).     
1.7 Growth requirements 
 Most Brucella strains have much more exacting nutritional 
requirements, especially on primary isolation. In general, several amino acids 
and minerals e.g. thiamin, biotin, nicotinamide, magneseium, iron and 
manganese are required for growth. All Brucella strains are aerobic but some 
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may grow best in a carbon dioxide-enriched atmosphere. No growth occurs in 
strictly anaerobic conditions. The optimum temperature for growth is about 
370C but growth occurs in the range (20-40)0C. For the isolation of brucella 
from contaminated materials, the use of selective media is generally required. 
Various formulations have been developed but the most generally useful are 
based on that of Farrell (1974). This contains bacitracin, cycloheximide, 
nalidixic acid, nystatin, polymyxin B and vancomycin in a serum dextrose agar 
base. This formulation is too inhibitory for the isolation of some Brucella 
strains, particularly B. ovis, for this, a medium containing vancomycin, 
colistimethate, nystatin and nitrofurantoin has been recommended (Brown et 
al., 1971). For the isolation of Brucella from human blood or bone marrow 
samples, a 2-phase culture system of the type devised by Castañeda (1947) is 
recommended. However, Tryptone Soy and Thioglycolate broths are also used 
for blood culture, but contamination due to repeated subcultures is a possible 
consequent unlikely to occur with the Castañeda medium (Cheesbrough, 
2000). 
1.8 Classification 
 The genus brucella comprises a group of closely related bacteria. 
Molecular genetic studies have indicated that the genus contains only a single 
species differentiated into a number of biovars, with certain host preferences. 
The taxonomic validity of this viewpoint has been accepted but the proposed 
new nomenclature, which would identify all members of the genus as biovars 
of B. melitensis, has been met with opposition on practical ground (Corbel, 
1998). According to Jinkyung and Spliter, (2003); currently there are seven 
nomen species classified as follows: 
1.8.1 B. melitensis 
 It is the first member of the group, and was isolated by Bruce in (1887) 
from spleen tissue of patients died of Malta fever. Because of its cocoid 
morphology in vivo and on primary culture in vitro, the organism was 
described as a micrococcus. The name micrococcus melitensis appeared 
earlier. Sheep and goats are the preferred natural hosts of B. melitensis, but 
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other animals may also be infected. As with other member of the genus, B. 
melitensis tends to localize in the reticuloendothelial system and the genital 
tract; genital infection of the pregnant female typically results in abortion. 
Humans are susceptible to infection, often manifest initially as an acute febrile 
illness which have described by various names including Malta fever, 
Mediterranean fever, and undulant fever. Chronic complications may succeed 
the acute phase and the term brucellosis is used as a convenient description for 
all phases of the disease.  
2.8.2 Brucella abortus 
It is the second member of the group, and was discovered by Bang in (1897), 
who isolated the organism from cows with contagious abortion, and by a series 
of experiments demonstrated its specific role in this disease. Cattle are the 
preferred natural host of this organism but it can also infect other animals. 
Although usually less virulent than B. melitensis, it can also cause brucellosis 
in humans. The relationship between B. abortus and b. melitensis was not 
appreciated until attention was drawn by their similarities by Evans (1914). 
This led Meyer and Shaw (1920) to propose the genus Brucella to include both 
organisms.  
1.8.3 Brucella suis 
 It was reported as the third member of the genus Brucella. It was first 
reported in (1914) by Traum, who reported its isolation from a fetus of a sow. 
It is a natural parasite of pigs, frequently producing a generalized infection but 
with a tendency to localize in the genital tract. Infection can also be transmitted 
to other animals, although the host range tends to be narrower than that of B. 
abortus and B. melitensis, possibly for geographical rather that biological 
reasons. In contrast with the B. suis strains described by Traum (1914), other 
types have been found which showed a different range and pathogenicity. 
Thus, Thomsen (1934) isolated from pigs in Denmark, strains which differed 
in certain cultural properties from those found in the USA, and were less 
pathogenic for humans. These Danish or European porcine strains have hares 
and swine as their natural hosts, and have been classified as B. suis biogroup 
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(‘biovar’) 2. The American strains have been assigned to B. suis biogroups 1 
and 3. Two additional B. suis biogroups have also been defined, neither of 
which cause natural infection in swine. B. suis biogroup 4 described earlier as a 
separate species "B. rangiferi tarandi" was associated with brucellosis in 
reindeer in Alaska, Canada, and Northern Russia, and causing reproductive 
failure (Davydov, 1961). It is transmissible to humans and causes an undulant-
fever syndrome. B. suis biogroup 5 has only been found in mouse-like rodents 
in the Caucasus. However, it is known to be pathogenic for humans and causes 
a disease similar to that produced by the other B. suis biogroups. Generally, B. 
suis strains are less widely distributed geographically than B. abortus or B. 
melitensis (Vershilova et al., 1983) 
1.8.4 Brucella ovis 
 The fourth member of the Brucella group, B. ovis was first observed at 
about the same time in Australia and New Zealand (Buddle and Boyes, 1953) 
and identified as the cause of epididymitis in rams. It has since been found in 
most other sheep-raising countries including Argentina, Chile, France, 
Germany, South Africa, USA, Spain and countries of the former Soviet Union. 
Although serological evidence suggests that human can be infected by this 
organism, it has not been confirmed to be a cause of overt disease. 
1.8.5 Brucella neotomae 
 The fifth member, B. neotomae, was isolated by Stoenner and lackman 
(1957) from desert wood rats in USA. It has not been associated with disease 
in humans or other species and further isolates have not been recorded. 
1.8.6 Brucella canis 
 The sixth member of the genus, B. canis, was reported by Carmichael 
and Bruner (1968) as the cause of abortion in beagle dogs in the USA. It has 
since been found in dogs of various breeds in many countries. Occasional cases 
have also been reported in humans, usually presenting as a mild pyrexial 
illness. 
 Unlike B. abortus, B. melitensis and B. suis, in which virulence is 
associated with the smooth colonial form, B. canis and B. ovis have been found 
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only in the non smooth phase. This has implications for the serological 
diagnosis of infections caused by these organisms because smooth and non-
smooth brucella strains are antigenically distinct. 
2.8.7 Brucella maris 
 Recently, Brucella maris strain has been isolated from marine mammals 
(Ross et al., 1994). The isolates comprise at least two distinct biogroups 
corresponding to strains of cetacean and phocine origin. Within these groups 
there is some variations in metabolic and antigenic properties. However it is 
apparent that these isolates differ from the Brucella strains infecting terrestrial 
mammals. They appear to have low pathogenicity for ruminants but 
circumstantial evidence suggests that they are pathogenic for humans. 
1.9 Epidemiology  
 Worldwide, brucellosis remains a major source of disease in humans 
and domestic animals. Although reported incidence and prevalence of the 
disease vary widely from country to country, bovine brucellosis caused mainly 
by B. abortus is still the most widespread form (Tables 2-6). In humans, 
ovine/caprine brucellosis caused by B. melitensis is by far the most important 
clinically apparent disease. The disease has a limited geographic distribution, 
but remains a major problem in the Mediterranean region, western Asia, and 
parts of Africa and Latin America. Recent reemergence in Malta and Oman 
indicates the difficulty of eradicating this infection (Amato, 1995). Sheep and 
goats and their products remain the main source of infection, but B. melitensis 
in cattle has emerged as an important problem in some southern European 
countries, Israel, Kuwait, and Saudi Arabia. B. melitensis infection is 
particularly problematic because B. abortus vaccines do not protect effectively 
against B. melitensis infection; the B. melitensis Rev.1. vaccine has not been 
fully evaluated for use in cattle. Thus, bovine B. melitensis infection is 
emerging as an increasingly serious public health problem in some countries 
(Corbel, 1997). A related problem has been noted in some South American 
countries, particularly Brazil and Colombia, where B. suis biovar 1 has become 
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established in cattle. In some areas, cattle are now more important than pigs as 
a source of human infection (Garcia 1990).  
 The true incidence of human brucellosis is unknown. Reported 
incidence in endemic-disease areas varies widely, from <0.01 to >200 per 
100,000 population (Lopez Merino, 1989). While some areas, such as Peru, 
Kuwait, and parts of Saudi Arabia, have a very high incidence of acute 
infections, the low incidence reported in other known brucellosis-endemic 
areas may reflect low levels of surveillance and reporting, although other 
factors such as methods of food preparation, heat treatment of dairy products, 
and direct contact with animals also influence the risk of infection to the 
population. Prevention of human brucellosis depends on the control of the 
disease in animals. The greatest success has been achieved in eradicating the 
bovine disease, mainly in industrialized countries (Table 7). Despite of the 
reported control programs in most countries, B. melitensis infection has proved 
more intractable and success has been limited (Table 8). Moreover, few recent 
outbreaks of disease caused by B. suis biovar four have been reported and foci 
of the infection persist in the Arctic regions of North America and Russia and 
constitute a potential hazard for the local population (Tessaro, 1986). B. ovis 
has not been demonstrated to cause overt disease in humans, although it is 
widespread in sheep (Tables 2-6)). B. canis can cause disease in humans, 
although this is rare even in countries where the infection is common in dogs 
(Carmichael, 1990). Precise information on prevalence is lacking, but B. canis 
has been recorded in the United States, Mexico, Argentina, Spain, China, 
Japan, Tunisia, and other countries. The recent isolation of distinctive Brucella 
strains, tentatively named Brucella maris, from marine animals in the United 
Kingdom and in the United States extends the ecologic range of the genus and, 
potentially, its scope as a zoonoses (Ross et al., 1994; and Ewalt, 1994)). 
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Table 2. Brucellosis in animals, Europe, 1994  
Country Bovine 
(B. 
abortus) 
Ovine/ 
caprine 
(B. melitensis) 
Porcine 
(B. suis) 
Ovine  
(B. ovis) 
Albania - + + + 
Belgium + - - - 
Bulgaria - - + + 
Croatia - - + + 
Czech - - ? - 
Republic      
France + ++ ? + 
Germany + - ? + 
Greece + ++ ND ND 
Ireland + - - - 
Italy + + - ND 
Latvia - - + - 
Lithuania - - - ? 
Macedonia + + - - 
Malta + + - - 
Poland + + ? - 
Portugal + + - + 
Romania - - + - 
Russia ++ ++ + + 
Slovakia - - ND - 
Slovenia - - - + 
Spain + + - + 
Ukraine ND ND ND ND 
Yugoslavia + + + - 
- not present., + low sporadic incidence., ++ high incidence.,  ?  
presence uncertain, ND = no data. None of the four types of brucellosis 
is present in Austria, Denmark, Estonia, Finland, Hungary, Iceland, 
Luxembourg, Moldavia, Netherlands, Sweden, Switzerland, and the 
United Kingdom.  
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     Table 3. Brucellosis in animals, Africa, 1994. 
 
 
      
 
 
 
 
 
 
Country Bovine 
(B. 
abortus) 
Ovine/ 
caprine 
(B. melitensis) 
Porcine 
(B. suis) 
Ovine  
(B. 
ovis) 
Algeria + ? ND + 
Angola ? ? ? ? 
Botswana + ND - ND 
Cape Verde ? ? ? + 
Central African 
Republic 
++ ND + ND 
Chad ++ ? ? ND 
Congo + - - - 
Côte d'Ivoire + - - + 
Egypt + + ND - 
Eritrea + ? ND + 
Ghana + - - - 
Guinea + ND - ND 
Kenya + + ND ND 
Libya + + - - 
Mauritius - - - - 
Morocco + ? - - 
Mozambique ++ + ++ + 
Namibia + - - ? 
Niger + + ND + 
Nigeria ++ + + ND 
Seychelles + - - - 
South Africa ++ + - + 
Sudan ++ + - - 
Tanzania + ND ND ND 
Tunisia + ++ - - 
Zaire + ND + ND 
Zimbabwe + + - + 
- not present., + low sporadic incidence., ++ high incidence.,  ?  
presence uncertain, ND = no data . No data on any of the four types of  
brucellosis are available for Gambia, Mali, and Mauritania.  
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     Table 4. Brucellosis in animals, Asia, 1994 
 
Country Bovine 
(B. 
abortus) 
Ovine/ 
caprine 
(B. melitensis) 
Porcine
(B. 
suis) 
Ovine  
(B. ovis) 
Afghanistan + + ND ND 
Bangladesh + + ND ND 
Bhutan + - - ND 
China + + + + 
Hong Kong ND ND ? ND 
India + + ?+ - 
Indonesia + ND + + 
Iran + + - - 
Israel - + - - 
Iraq + + ND ND 
Jordan - ++ - - 
Korea (S) ++ - ?+ - 
Kuwait ++ ++ - - 
Malaysia + - ?- - 
Mongolia ++ + - + 
Myanmar + ND + ND 
Oman ++ ND ND ND 
Qatar ND ND ND ND 
Sri Lanka ++ + - + 
Syria + ND ND ND 
Thailand + - + - 
Turkey ++ ++ - ND 
UAE - + - + 
Yemen + + - - 
- Not present., + low sporadic incidence., ++ high incidence.,  ?  
Presence uncertain, ND = no data. None of the four types of 
brucellosis is present in Bahrain, Cyprus, Japan, Malaysia (Sabah), 
Philippines, or Singapore. No data for countries of the former Soviet 
Union or Qatar.  
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Table 5. Brucellosis in animals, the Americas, 1994 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Country Bovine 
(B. 
abortus) 
Ovine/ 
caprine 
(B. melitensis) 
Porcine 
(B. suis) 
Ovine  
(B. ovis) 
Antigua/ 
Barbuda 
? - - - 
Argentina ++ - + ++ 
Belize - - - ND 
Bolivia ++ + + ND 
Brazil ++ - + - 
Canada - - - + 
Chile ++ - - + 
Colombia + - - - 
Cuba ? - ++ - 
Dominican 
Republic 
++ - + - 
Ecuador ++ ND ND ND 
El Salvador ++ ND + ND 
Guatemala + - + - 
Haiti + - - - 
Honduras ? - ++ - 
Jamaica ?+ - - - 
Mexico + + ND - 
Nicaragua ++ ND ND ND 
Peru ++ ND ND ++ 
Paraguay + ND - + 
Uruguay + - - + 
United States + - (+) + 
Venezuela ++ - ++ ? 
- not present., + low sporadic incidence., ++ high incidence.,  ?  
presence uncertain, ND = no data . None of the four types of 
brucellosis is present in Barbados, Falkland Islands, Surinam, or St. 
Kitts/Nevis.  
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Table 6. Brucellosis in animals, Oceania, 1994 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 7. Countries reporting eradication of bovine brucellosis, 1994 
 
EUROPE    
Bulgaria (1958) Croatia (1965) Czech Republic (1964) 
Denmark (1962) Estonia (1961) Finland (1960) 
Hungary (1985) Iceland (never recorded) Latvia (1963) 
Lithuania (1952) Luxembourg (1993) Netherlands (1993) 
Romania (1969) Slovak Republic (1964) Slovenia (1970) 
Sweden (1957) Switzerland (1963) U.K (1993) 
AFRICA    
Mauritius (1986)   
AMERICAS    
Belize (1980) Canada (1989)  
ASIA    
Cyprus (1932) Israel (1984) Japan (1992) 
Jordan (1992) N Korea (1959) Papua New Guinea 1974) 
Philippines (1989) U.A.E. (1992)  
OCEANIA    
Australia (1989) French Polynesia (1984)  
New Zealand 
(1989) 
Vanuatu (1992)   
 
 
 
 
 
 
 
 
 
 
Country Bovine 
(B. 
abortus) 
Ovine/ 
caprine 
(B. melitensis)
Porcine 
(B. suis) 
Ovine  
(B. 
ovis) 
Australia - - (+) +  
Cook Island - ND - ND  
New Caledonia - - - -  
New Zealand - - - ++  
Samoa + ND ND ND  
++   high prevalence., +   present., (+)   limited presence., -   not 
present., ND   no data. None of the four types of brucellosis is present 
in Vanuatu.  
Prevalence of brucellosis 
  
Table 8. Countries reporting eradication of other forms of brucellosis, 1994 
 
Source of tables (2-8): FAO-WHO-OIE, Animal Health Yearbooks,1994-1995. 
 
1.9.1 Transmission. 
 Transmission of B. abortus is very likely to occur via the oral route 
because cattle tend to lick aborted fetuses and the genital discharge of an 
aborting cow (Cunningham, 1977). Congenital infection can occur in newborn 
calves as a result of in-utero infection and the infection may persist in a small 
proportion of calves which may also be serologically negative until after their 
first parturition or abortion (Blood et al., 1983). Exposure to brucellae is also 
likely to occur when calves born to healthy dams and fed on colostrum or milk 
from infected dams (Bercovich et al.,1990). It has been established that 
brucellosis in bulls does not always result in infertility, although semen quality 
may be affected. Bulls that remain fertile and functionally active will shed 
Brucella organisms with the semen during the acute phase of the disease. 
Region Ovine/caprine (B. 
melitensis) 
Porcine (B. 
suis) 
Ovine (B. ovis) 
Europe    
 Bulgaria (1941) Denmark 
(1951) 
Czech Rep. (1951) 
 Croatia (1991) Estonia (1988) Germany (1986) 
 Czech Rep. (1951) Lithuania 
(1991) 
Latvia (1989) 
 Germany (1986) Sweden (1957)  
 Switzerland (1963)   
Africa     
 Ghana (1993) Namibia (1990) Ghana (1993) 
Americas     
 United States (1972) Belize(1985) Falkland Is. 
(1991) 
 Chile (1987) Honduras 
(1992) 
Mexico (1991) 
  Colombia 
(1982) 
 
Asia     
 Cyprus (1993) Singapore(1989
) 
Yemen (1989) 
Oceania Not present None None 
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Shedding, however, may cease or become intermittent (McCaughey et al., 
1973). In contrast to artificial insemination, bulls used in natural service may 
fail to spread the infection, as the infected semen is not deposited in the uterus 
(Ray, 1979). While indirect exposure to Brucella organisms could be mediated 
by wildlife, birds and waterways (contaminated with urine, uterine discharge, 
or slurry from aborting cattle). It seems that only dogs carry pieces of placentae 
or aborted fetuses from one place to another causing direct exposure (Forbes, 
1990). Contamination of a cowshed or pasture takes place when infected cattle 
abort or have full-term parturition. Although it is generally accepted that B. 
abortus is not excreted for any considerable time before abortion occurs, 
excretion in the vaginal discharges of infected cattle may occur as early as 39 
days after exposure (Philippon et al., 1970). A massive excretion of brucellae 
starts after abortion and may continue for 15 days. Once the fetal membranes 
are expelled the uterine discharges diminish and the number of Brucella 
organisms excreted decreases rapidly (Nicoletti, 1980). Although the infectious 
material from the genital tract usually clears after 2-3 months, some infected 
cattle become carriers of Brucella and excrete it intermittently for many years 
(Philippon et al., 1970). Infected udders are clinically normal but they are 
important as a source of re-infection of uterus, infection for calves or human 
drinking the milk.   
 Humans are generally infected in one of three ways: eating or drinking 
something that is contaminated with Brucella, breathing in the organism 
(inhalation), or having the bacteria enter the body through skin wounds 
(Godfroid et al., 2005). Consumption of contaminated foods (most likely 
eating or drinking contaminated milk or milk products) and occupational 
contact remain the major sources of infection for humans. Occupational 
disease is contracted by exposure of abattoir workers and veterinarians to 
infected animals especially aborted fetuses, fluids, membranes or urine (Nimri, 
2003). Inhalation of Brucella organisms is not a common route of infection, 
but it can be a significant hazard for people in certain occupations, such as 
those working in laboratories where the organism is cultured. Inhalation is also 
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responsible for a significant percentage of cases in abattoir employees. 
Contamination of skin wounds may be a problem for persons working in 
slaughterhouses or meat packing plants. Hunters may be infected through skin 
wounds or accidentally by ingesting the bacteria after cleaning deer, elk, 
moose, or wild pigs that they have killed (Godfroid et al., 2005). Direct 
person-to-person spread of brucellosis is extremely rare. Mothers who are 
breast-feeding may transmit the infection to their infants. Sexual transmission 
has also been reported. Uncommon transmission may also occur via 
contaminated tissue transplantation (Geoffrey et al., 2002) 
1.10 Pathogenesis  
 Although epidemiological evidence suggests that B. abortus, B. 
melitensis and B. suis show distinct host preferences, this only marks a general 
trend and the organisms are capable of establishing infection in a wide range of 
host species, including humans. B. neotomae, B. canis and B. ovis in contrast, 
show much greater host specificity, and with the exception of occasional B. 
canis infections in carnivores and in humans seem to have little capacity to 
spread beyond their usual hosts (Corbel, 1998). 
1.10.1 Animal host  
 Typically, in all host species Brucella grows intracellulary in the 
macrophages. Abortion is a frequent consequence of infection in the pregnant 
female, and orchitis and epididymitis can result in the male. Sexually immature 
animals are often less susceptible to the disease. Brucella spp. has a 
predilection for the pregnant uterus, udder, testicle and the accessory male sex 
glands, lymph nodes, joint capsules and bursae. Erythritol, a substance 
produced by the fetus and capable of stimulating the growth of Brucella spp. 
occurs naturally in greatest concentration in the placental and fetal fluids and is 
probably responsible for localization of infection in these tissues. In the adult 
non-pregnant cow, localization occurs in the udder, and the uterus, if it become 
gravid, is infected from periodic bacteraemic phases originating in the udder. 
When the invasion of the gravid uterus occurs the initial lesion is in the wall of 
the uterus and spread to lumen of the uterus soon follows, leading to a severe 
Prevalence of brucellosis 
  
ulcerative endometritis of the inter-cotyledonary spaces. The allantochorion, 
fetal fluids and placental cotyledons are next invaded and the villi destroyed. 
Abortion occurs principally in the last trimester of pregnancy, the incubation 
period being inversely proportional to the stage of development of the fetus at 
the time of infection (Blood et al, 1983).  
1.10.2 Human host  
 The organism progress from the portal of entry, via lymphatic channels 
and regional lymph nodes, to the thoracic duct and the blood stream, which 
distributes them to the parenchymatous organs. Granulomatous nodules that 
may develop into abscesses from lymphatic tissues, liver, spleen, bone marrow, 
and other parts of the reticuloendothelial system. In such lesions, the brucellae 
are principally intracellular. Osteomyelitis, meningitis, or cholecystitis also 
occasionally occurs. The main histological reaction in brucellosis consists of 
proliferation of mononuclear cells, exudation of fibrin, coagulation necrosis 
and fibrosis. The granulomas consist of epitheloid and giant cells, with central 
necrosis and peripheral fibrosis. The four Brucellae that infect humans have 
apparent differences in pathogenicity. B. abortus usually causes mild disease 
without suppurative complications; non-caseating granulomas of the 
reticuloendothelial system are found. B. canis also causes mild disease. B. suis 
infection tends to be chronic with suppurative lesions; caseating granulomas 
may be present. B. melitensis infection is more acute and severe. Persons with 
active brucellosis react more markedly (fever, myalgia) than normal persons to 
injected Brucella endotoxin. Sensitivity to endotoxin thus may play a role in 
pathogenesis (Farrell, 1996).  
1.11 Diagnosis of brucellosis 
1.11.1 Human Brucellosis 
Man is usually infected with Brucella organisms by direct contact with infected 
animals or indirectly by contamination dairy products, contaminated dusts or 
aerosols, or by accidental exposure to animal vaccines or laboratory cultures. 
Veterinarians, farmers, abattoir workers and laboratory staff are at times in 
occupational contact with the organism and are often infected. The organism 
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may establish infection by ingestion, or pass through abrasions on the skin, or 
cross mucous membranes or by accidental inoculation of vaccine or laboratory 
strains. The diagnosis of human Brucellosis is usually performed upon a set of 
clinical examinations and laboratory procedures. Symptoms (such as fever, 
headache, loss of weight, profuse sweating and myalgia) and physical signs 
(palpable spleen and liver, leucopenia, lymphocytosis) in addition to a clear 
history of exposure to brucellae is suggestive for brucellosis. However, 
diagnosis should be confirmed by bacteriological and/or serological means 
(Farrell, 1996). 
1.11.1.1 Culture of brucellae 
 When infection is due to B. melitensis or B. suis, little difficulty is 
encountered in isolating the infecting organism from blood during the febrile 
episodes of the illness. But blood cultures are often negative in B. abortus 
infections. An attempt should always be made to isolate brucellae from 
patient’s blood during the febrile stage of the disease. Approximately 5ml of 
blood should be inoculated into blood culture bottles containing Tryptone soy 
broth. The bottles should be sub cultured twice a wk for 8 wks on to Tryptone 
soy agar. The Castañeda biphasic blood culture technique may be useful in 
reducing the risk of contamination during the long period of incubation. When 
B. abortus infection is a possibility, incubation should be in an atmosphere with 
added 5-10% CO2. Blood cultures should be maintained for at least 8 wks 
before they are discarded as negative. 
1.11.1.2 Serological tests 
 When the infectious organism was not isolated from blood or other 
clinical materials, serological investigations of the patient is of paramount 
importance for the diagnosis of the disease and future management of the 
patient. As culture is not invariably successful, serum samples should be 
collected as soon as possible and at various stages of the illness. Brucella 
antibodies can be detected by a variety of serological tests. The most widely 
used are the Standard Agglutination Test (SAT) and the Compliment Fixation 
Test (CFT). Additional information can be obtained by other techniques such 
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as the Mercaptoethanol (ME) agglutination test, Radio Immune Assays (RIA), 
Enzyme-linked Immuno-sorbent Assay (ELISA) and recently Polymerase 
Chain Reaction (PCR). These techniques have been shown to be useful in the 
diagnosis of human Brucellosis. As Brucella antibodies may be detectable for 
many years after acute or sub clinical infection, the possibility of residual 
antibody from a previous infection must be borne in mind when considering the 
significance of Brucella antibodies in a patient’s serum. False-positive 
reactions have been described due to cross-reactivity with strains of E. Coli, 
Salmonella Urbana and other group N serotypes, Vibrio Cholerae, Yersinia 
enterocolitica and Francisella tularensis (Corbel, 1979). 
In persons whose symptoms are of recent onset, the presence of low titre of 
antibodies may be significant and in such instances a rising titre may be 
demonstrated by the SAT or CFT and can be of considerable help in 
confirming the clinical diagnosis. It is at this stage of the disease that the 
significant amount of IgM antibody is present; this indicated by the presence of 
ME-sensitive agglutinins or can be shown more directly by ELISA or RIA 
(Farrell, 1996).  
1.11.2 Bovine brucellosis  
1.11.2.1 Clinical signs  
 The clinical findings are dependent upon the immune status of the herd. 
In highly susceptible non-vaccinated pregnant cattle, abortion after the fifth 
month of pregnancy is the cardinal feature of the disease in cows. In 
subsequent pregnancies the fetus is usually carried to full term although second 
or third abortion may occur in the same cow. Retention of the placenta and 
endometritis are common sequellae to abortion. Mixed infections are usually 
the cause of the metritis which may be acute, with septicemia and death 
following, or chronic, leading to sterility. In the bull, orchitis or epididymitis 
occur occasionally. One or both scrotal sacs may be affected with a cute, 
painful swelling to twice normal size although the testis may not be grossly 
enlarged. The swelling persists for considerable time and the testis undergoes 
liquefaction necrosis and is eventually destroyed (Blood et al., 1983). 
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1.11.2.2 Bacteriological examination 
Bacteriological examination of aborting cattle is the method of choice for 
diagnosing early infections (Erasmus, 1986). However, the procedure is 
laborious, time consuming, costly and cannot routinely be used as a diagnostic 
procedure in developed or developing countries.  Moreover, the probability of 
successful recovery of Brucella spp. is strongly reduced when the material is 
heavily contaminated and negative culture results do not exclude infection. 
Direct isolation and culture of Brucella are usually performed on solid media. 
This is generally the most satisfactory method as it enables the developing 
colonies to be isolated and recognized clearly. Such media also limit the 
establishment of non-smooth mutants and excessive development of 
contaminants. However, the use of liquid media may be recommended for 
voluminous samples or for enrichment purpose. A wide range of commercial 
dehydrated basal media is available, e.g. Brucella Medium Base, Trypicase (or 
tryptone)–Soy Agar (TSA). The addition of 2–5% bovine or equine serum is 
necessary for the growth of strains such as B. abortus biovar 2. Other 
satisfactory media, such as Serum–Dextrose Agar (SDA) or glycerol dextrose 
agar, can be used (Alton, 1988). SDA is usually preferred for observation of 
colonial morphology. A nonselective, biphasic medium, known as Castañeda’s 
medium, is recommended for the isolation of brucella from blood and other 
body fluids or milk, where enrichment culture is usually advised. Castañeda’s 
medium is used because brucellae tend to dissociate in broth medium, and this 
interferes with biotyping by conventional bacteriological techniques. All the 
basal media mentioned above can be used for the preparation of selective 
media. Appropriate antibiotics are added to suppress the growth of organisms 
other than Brucella. The most widely used selective medium is the Farrell’s 
medium, which is prepared by the addition of six antibiotics to a basal medium. 
The following quantities are added to 1 litre of agar: polymyxin B sulphate 
(5000 units = 5 mg); bacitracin (25,000 units=25 mg); natamycin (50 mg); 
nalidixic acid (5 mg); nystatin (100,000 units); vancomycin (20 mg) (O.I.E 
manual, 1996). The sensitivity for B. melitensis isolation increases significantly 
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by the simultaneous use of both Farrell’s and the modified Thayer–Martin 
medium. Contrary to several biovars of B. abortus, growth of B. melitensis is 
not dependent on an atmosphere of 5–10% CO2 (O.I.E manual, 2004). 
1.11.2.3 Serological tests 
         Body fluids such as serum, uterine discharge, vaginal mucus, milk, or 
semen plasma from suspected animal may contain quantities of different 
antibodies types directed against brucellae. Because infected animal may or 
may not produce all antibody types in detectable quantities, several tests are 
used to detect brucellosis. The commonly used tests are the Milk Ring Test 
(MRT), Serum Agglutination Test (SAT), Complement Fixation Test (CFT), 
Rose Bengal  Plate Test (RBPT), Anti-globulin (Coombs) Test, 2-
mercaptoethanol (Rivanol) and the Enzyme-linked Immuno-sorbent Assay 
(ELISA). The use of several tests to reliably detect brucellosis suggests 
shortcomings in each of the tests.  
1.11.2.3.1 The Milk Ring Test (MRT) 
          Is cheap, easy, simple and quick to perform. It detects lacteal anti- 
Brucella IgM and IgA bound to milk fat globules. However, it tests false 
positive when milk that contains colostrum, milk at the end of the lactation 
period, milk from cows suffering from a hormonal disorder or milk from cows 
with mastitis are tested (Bercovich and Moerman, 1979). Milk that contains 
low concentrations of lacteal IgM and IgA or which is lacking the fat-clustering 
factors show false-negative results (Keer et al., 1959; Tanwani and Pathak, 
1971; Patterson and Deyoe, 1978). Because lacteal antibodies rapidly decline 
after abortion or parturition, the reliability of the MRT, using 1 ml milk, to 
detect Brucella antibodies in individual animals or in tank milk is strongly 
reduced (Hill, 1966). Although the MRT performed with 8 ml milk it improved 
the detection of brucellosis in tank milk (Bercovich and Lagendijk, 1978), it 
may test false positive when traces of colostrum are present in tank milk. 
1.11.2.3.2 The serum agglutination test (SAT) 
        Which historically has been the principal serological test used to detect 
brucellosis, measures agglutinating antibodies of the IgM, IgG1, IgG2, and IgA 
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types (Levieux, 1974). The SAT is relatively simple and easy to perform but it 
requires basic laboratory equipment. It can be used to detects acute infections, 
as antibodies of the IgM type usually appear first after infection and are more 
reactive in the SAT than antibodies of the IgG1 and IgG2 types (Levieux, 
1974). However, because the SAT may yield both false negative or false 
positive results (Corbel et al., 1984) it effectively detects brucellosis only on a 
herd basis. The antigen is a bacterial suspension in phenol saline i.e. NaCl 0.85 
% w/v and phenol at 0.5 % v/v. Antigens may be delivered in the concentrated 
state provided the dilution factor to be used is indicated on the bottle label. 
EDTA may be added to the antigen suspension to 5 mM final test dilution to 
reduce the level of false-positive results.  Subsequently the pH of 7.2 must be 
re-adjusted in the antigen suspension. The antigen shall be prepared without 
reference to the cell concentration, but its sensitivity must be standardized in 
relation to the OIE standards in such a way that the antigen produces either 
50% agglutination with a final serum dilution of 1/600 to 1/1000 or 75% 
agglutination with a final serum dilution of 1/500 to 1/750. It may also be 
advisable to compare the reactivity of new and previously standardized batches 
of antigen using a panel of defined sera. The test is performed either in tubes or 
in microplates. The mixture of antigen and serum dilutions should be incubated 
for 16–24 hours at 37°C. If the test is carried out in microplates, the incubation 
time can be shortened to 6 hours. At least three dilutions must be prepared for 
each serum in order to refute prozone negative responders. Dilutions of suspect 
serum must be made in such a way that the reading of the reaction at the 
positivity limit is made in the median tube (or well for the microplate method). 
Interpretation of agglutination results must be expressed in IU per ml. A serum 
containing 30 or more IU per ml is considered to be positive (OIE, 2005). 
1.11.2.3.3 The Complement Fixation Test (CFT) 
            Detects specific antibodies of the IgM and IgG 1type that fix 
complement (Hill, 1963 and Levieux, 1974). The CFT is highly specific (Hill, 
1963) but it is laborious and requires highly trained personnel as well as 
suitable laboratory facilities. This makes the CFT less suitable for use in 
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developing countries. Although its specificity is very important for the control 
and eradication of brucellosis, it may show false negative results when 
antibodies of the IgG2 type hinder complement fixation (MacMillan, 1990). 
The CFT measures more antibodies of the IgG1 type than antibodies of the 
IgM type, as the latter are partially destroyed during inactivation. Since 
antibodies of the IgG1 type usually appears after antibodies of the IgM type. 
Control and surveillance for brucellosis is best done with SAT and CFT  
1.11.2.3.4 The Rose Bengal Plate Test (RBPT) 
        Is a spot agglutination technique. Because the test does not need special 
laboratory facilities and it is simple and easy to perform, it is used to screen 
sera for Brucella antibodies. The test detects specific antibodies of the IgM and 
IgG types and is more effective in detecting antibodies of the IgG1 type than 
IgM and IgG2 types (Levieux, 1974). The test may yield negative results in 
infected cattle that give positive results with the CFT (Rose and Roepke, 1957). 
Although the low pH (+3.6) of the antigen enhances the specificity of the test, 
the temperature of the antigen and the ambient temperature at which the 
reaction takes place may influence the sensitivity and specificity of the RBPT 
(MacMillan, 1990). 
1.11.2.3.5 The Anti-globulin (Coombs) Test: 
       Detects (incomplete Brucella) antibodies of the IgG2 type and is used to 
confirm SAT results (Hill, 1963). The Coombs test, although laborious, is 
particularly important when the SAT is positive and CFT results are negative or 
inconclusive (Kiss, 1971). However, Coombs test results are indicative for 
infection only when its titres are at least two times the titres of the SAT (Hill, 
1963). This is the tests main limitation, as not all infected cattle show this ratio.  
1.11.2.3.6 The 2-Mercaptoethanol and the Rivanol tests 
         Detects specific IgG (Rossi and Cantini, 1969) and are usually used to 
differentiate between infected and vaccinated cattle. 
1.11.2.3.7 Enzyme Linked Immunosorbent Assay (ELISA)  
            Nielsen et al., (1981) reviewed several ELISAs' procedures and the 
antigens, conjugates and substrates that can be used in the assay. The ELISA 
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has proven to be specific and as sensitive as the MRT and SAT in detecting 
Brucella antibodies in milk and serum. ELISA results are usually also in 
agreement with CFT results (Ruppanner and Taaijke, 1980;  and Stemshorn et 
al., 1980). The test can be used for screening and confirmation of brucellosis in 
both milk and serum. However, depending on the presence of traces of 
colostrum in the milk, or the presence of low concentrations of lacteal 
immunoglobulin the ELISA may test false positive or false negative (Kerkhofs 
et al., 1990). Some researchers imply that the main advantage of the ELISA 
when compared with the CFT lies in its relative simple test procedure 
(Sutherland et al., 1986). The assay is very costly when only a few samples are 
tested; therefore, it is unsuitable for testing individual animals but it is the ideal 
test for screening suspected herds.  
1.11.2.3.8 Skin-Delayed-Type-Hypersensitivity Test (SDTHT)  
        Since the reliability of serological tests to detect brucellosis depends on 
antibodies that may or may not be present at the time of examination,  
inevitably some infected animals may elude detection. Because the skin-
delayed-type-hypersensitivity (SDTHT) is independent of circulating 
antibodies it should be added to the serological tests to improve detection of 
brucellosis. The SDTHT confirms serologic test results, confirms brucellosis in 
cattle with ambivalent serologic test results and detects latent carriers of 
Brucella. Furthermore, the SDTHT does not sensitize cattle for several 
consecutive SDTHT (Bercovich, 1999). Therefore, the SDTHT should be the 
test of choice in developing countries, as cattle in those countries are usually 
not tagged so that serological test results could be related to the individual 
animal. Where the animals are tagged a combined use of the SAT and SDTHT 
increase the reliability of brucellosis diagnosis (Bercovich, 1999). 
1.11.2.3.9 Nucleic Acid Recognition Methods  
         The recently developed PCR provides an additional means of detection 
and identification of Brucella spp. Despite the high degree of DNA homology 
within the genus Brucella, several molecular methods, including PCR, PCR 
restriction fragment length polymorphism (RFLP) and Southern blot, have been 
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developed that allow, to a certain extent, differentiation between Brucella 
species and some of their biovars. Pulse-field gel electrophoresis has been 
developed that allows the differentiation of several Brucella species. However 
none of these methods has been fully evaluated and standardized and none is 
widely available (O.I.E manual, 1996).  
1.12 Treatment of brucellosis 
1.12.1: Human brucellosis 
 The appropriate antibiotic therapy for brucellosis has been studied to 
some degree. Doxycycline (100 mg PO bid for 6 wk) is the most appropriate 
monotherapy in simple infection; however, relapse rates approach 40% for 
monotherapy treatment. Rifampicin (600-900 mg/d) usually is added to 
doxycycline for a full 6-week course. In patients with spondylitis or sacroiliitis, 
doxycycline plus streptomycin (1g/d IM for 3 wk) was found to be more 
effective than the doxycycline/rifampicin combination. Streptomycin currently 
is favored over rifampicin for combination therapy of any significant infection. 
In pediatric patients older than 8 years, doxycycline (5 mg/kg/d for 3 wk) plus 
gentamicin (5 mg/kg/d IM for the first 5 d) was the recommended therapy. For 
children younger than 8 years, trimethoprim/sulfamethoxazole (TMP-SMZ) for 
3 weeks and a 5-day course of gentamicin were most effective. TMP-SMZ also 
was effective in treating pregnant women, either as a single agent or in 
combination with rifampicin or Gentamicin (Corbel, 1998). Fluoroquinolones 
have a high relapse rate when used as monotherapy. No uniform 
recommendation exists for treatment of meningitis or endocarditis; however, 
TMP-SMZ plus rifampicin remains the preferred combination. In endocarditis, 
early replacement of the infected valve is recommended, along with medical 
therapy. Corticosteroids are recommended in CNS infection, but data 
supporting their utility are lacking (Maloney, 2001). The combination therapies 
recommended by FAO/WHO, (1986), for treatment of brucellosis are 
doxycycline plus rifampicin or doxycycline plus streptomycin. Although highly 
successful results have been obtained with these two regimens, relapse rates are 
as high as 14.4% (Corbel, 1997). The most effective and the least toxic 
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chemotherapy for human brucellosis is still undetermined (Oguz Karabay et al., 
2004). 
1.12.2 Bovine brucellosis  
 Antibiotic therapy is rarely employed in the treatment of bovine 
brucellosis. Nevertheless; in case of genetically valued animals or herds, 
treatment may be performed to control spread of the disease. Monotherapy by 
tetracyclines or aminoglycosides is very unsuccesfull (Nicoletti et al., 1985). 
While the combinations of oxytetracycline with streptomycin were found 
successful in stop milk shedding of the organisms (Jimenez de Bagues et al., 
1991) and prolonged treatment with the same combination found to have 100% 
of success (Radwan et al., 1993). 
1.13 Control measures 
1.13.1 Prevention of human brucellosis depends on 
• Eradication of Brucella species from cattle, goats, swine, and other 
animals. 
• Pasteurization of milk and milk products for human consumption, 
particularly important to prevent disease in children (Louisiana Office of 
Public Health, 2004). 
• Immunizations: There are several animal vaccines that are safe and 
effective; however, they are all pathogenic to man. Currently there are 
no vaccines approved for use in humans (Elzer, 2003). 
1.13.2 Control and eradication of bovine brucellosis 
 The control of the disease depends on the system of animal management 
(Musa, 2004). The approach to control, prevention, or eradication of brucellosis 
in a country or region will depend on many factors, such as the level of 
infection in the herds or flocks, type of husbandry, economic resources, public 
health impacts, and potential international trade implications. Decision-making 
by those charged with policy making is likely to be intuitive, unless accurate 
and current epidemiological information are available (Robinson, 2003). 
According to the FAO, guidelines: In the control and eventual eradication of 
brucellosis, there are generally four overlapping phases: 
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1. If there is no or minimal efforts to control the infection. Sporadic testing 
of animals may have been done, but usually for diagnostic purposes 
following abortion. Some herds or flocks may have been vaccinated. 
2. Intensive vaccination phase of herds and flocks, using either B. abortus 
(strain 19 or RB 51) or B. melitensis (strain Rev.1) to vaccinate either 
sexually immature or adult animals.  
3. Test and removal, segregation or slaughter phase of infected animals, 
with the ultimate aim of developing Brucella-free herds, flocks or 
regions of a country. During this phase, vaccination is usually phased 
out towards the end of the eradication programme.  
4. Freedom phase, where, once having eradicated the infection, intensive 
surveillance is maintained for at least five years to confirm that the agent 
is no longer present in the population.  
The choice of sampling and types of herds or flocks to monitor will obviously 
depend on the phase of brucellosis control. For example, once the prevalence of 
infected herds has been reduced to a low level, it is usually uneconomic to 
continue testing all eligible animals and surveillance can focus on problem 
herds, abortion incidents, herds adjacent to known infected herds and off-farm 
testing, such as in markets and slaughterhouses (Robinson, 2003; and Blood et 
al.,  1983) pointed out the following recommendations based on the need for 
flexibility in controlling the disease depending on the existent level of infection 
and the susceptibility of the herd and the disease regulations in effect at time: 
During an abortion storm:  
 Vaccination of all non-reactors. If testing is impractical, Vaccination of 
all cattle is recommended. Strain 19 is superior to K45/20A even though it may 
cause abortion in small percentage of animals. 
Heavily infected herds with few abortions:  
 In this case a degree of herd resistance has been reached. All calves 
should be vaccinated with strain 19. Positive reactors among the remainder 
should be culled. Periodic milk ring tests (at 2 month, no more than 3 month 
intervals) on individual cows are supplemented by complement fixation test 
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and culture. After one-year retest by agglutination test and revaccination with 
K45/20A is recommended. 
Lightly infected herds:  
 If these herds are situated in an area where infection is likely to be 
introduced, vaccination of calves and immediate culling of positive reactors 
should be carried out. In areas of dairy production, semi-annual testing by milk 
tests may be substituted for blood tests (Blood et al, 1983). 
 Despite tremendous efforts and financial investments, many European 
Mediterranean countries have yet to eradicate this disease. Many factors, in 
particular the types of husbandry system, may have contributed to the failure to 
effectively control the disease in these countries. The re-emergence of 
brucellosis as a major veterinary and public health problem in the former 
Soviet Republics during the past decade through a weakening of the veterinary 
system and transition from large government controlled farms to small-scale 
private farming, further emphasis the essential role of a continued and 
coordinated control effort. The transmission and spread of brucellosis is 
affected by a variety of factors and good knowledge of these is essential to the 
success of a control policy (Reviriego et al., 2000; Bikas et al., 2003; and 
Minas et al., 2004). In general, prevalence of brucellosis usually is higher and 
control more problematic in pastoral or migratory populations, practiced by a 
significant proportion of the agricultural population of Africa. Vaccination of 
livestock is crucial to the control of brucellosis. Effective reduction of disease 
prevalence in livestock through mass vaccination eventually will also lead to a 
reduction of brucellosis in the human population. However, vaccination alone 
is not sufficient and should be accompanied by other measures such as 
restriction of animal movement and trade, culling of infected animals and 
improved farm sanitation to reduce the further spread of disease. In addition, a 
surveillance system is essential to control the efficacy of control measures and 
to identify outbreaks at an early stage (Henk et al., 2004). Clearly the control of 
brucellosis requires significant efforts both in terms of human and financial 
resources and time. In Argentina and other countries in South and Central 
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America, brucellosis has been recognized as a disease problem since the 19th 
century, but in spite of control efforts starting in Argentina in 1932, the disease 
still is not considered to be controlled in this country (Samartino, 2002). 
Despite the situation in resource, poor countries control measures provided that 
they are adapted to the local situation and supported by the local population, 
together with improved diagnostics, could provide immediate cost-effective 
benefits. 
 Worldwide there are five Brucella vaccines for use in animal 
populations. These brucellosis vaccines are B. abortus 45/20, B. melitensis 
Rev-1, B. suis strain 2, B. abortus strain 19, and B. abortus RB51. The killed 
vaccine strain 45/20 did not consistently protect against virulent challenge.  B. 
suis strain 2 has not been evaluated extensively and can cause vaccinal titers 
which can not been distinguished from field strain titers.  Rev-1 provides 
protection in sheep and goats against brucellosis; however, it can cause 
abortions and vaccinal titers in some animals.  Strain 19 vaccine also protects 
cattle against brucellosis but may also cause abortions and titers, which 
interfere with routine diagnostic test.  It is not effective in wildlife species 
infected with B. abortus, primarily bison and elk.  Currently B. abortus strain 
RB51 is the only vaccine that does not cause vaccinal titers, which can be 
confused with field strain titers.  RB51 is approved for use in cattle and 
provides equivalent levels of protection as compared to Strain 19.  RB51 
appears to be safe in the majority of   ungulates and non-target species tested in 
that it does not cause abortion.  RB51 does cause abortions in pregnant 
reindeer, and it is not efficacious against virulent challenge in elk and bison. 
With no vaccines to protect wildlife, primarily bison, elk and feral swine carry 
brucellosis. It is imperative that new vaccine candidates be evaluated (Elzer, 
2002). The attenuated live B. abortus S19 vaccine is the recommended vaccine 
for bovine brucellosis (Nicoletti, 1990). The attenuated live B. melitensis Rev-1 
vaccine is recommended for goats and sheep. These attenuated strains are still 
smooth and consequently their use results in positive serology that can be 
confused with naturally infected animals. The live rough strain B. abortus 
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45/20 reverts to virulence in vivo and was subsequently used as a killed 
vaccine. Protective effect was limited and consequently its use should be 
avoided. Newly developed vaccines such as the B. abortus RB51 vaccine 
provide promising alternatives but require more extensive field studies and 
experience to establish its safety and efficacy. A safe and effective vaccine for 
brucellosis in man does not exist despite considerable efforts (Henk et al., 
2004).  
1.14 Economic importance of brucellosis  
 Nicoletti, (1982) mentioned that brucellosis can be a serious economic 
disease is unquestioned. Losses due to abortion or stillbirths, irregular breeding, 
loss of milk production and reduced human productivity are economic 
consequences. And that the reduced human productivity can hardly be measured in 
medical care. He referred to Shepherd et al., (1979) estimates of US$ 3,206 for 
each case. He also argues that quantitative estimates of the effects of disease on 
productivity of livestock are essential for justification of organized programmes. 
He based his argument on Shepherd et al., (1979) who concluded that there was an 
internal rate of 10.27% return on costs of programme to eradicate cattle 
brucellosis. These data were based upon assumption that infected non-aborting 
dairy cows produced at 10% below potential and aborters at 20%. He further 
estimated that 10-35% of infected cows abort each year. The economic loss from 
brucellosis in developed countries arises from the slaughter of cattle herds that are 
infected with Brucellosis. In developing countries loss arises from the actual 
abortion of calves and resulting decreased milk yield, birth of weak calves that die 
soon after birth, retention of placenta, impaired fertility and sometimes arthritis or 
bursitis. It is difficult to estimate the financial loss caused by brucellosis, as it 
depends on the type of cattle farming, herd size, and whether it is an intensive or 
extensive cattle farm. Furthermore, although it is very difficult to estimate the 
financial loss incurred by human brucellosis there is no doubt that it is substantial 
(FAO, 2003). The exact public health significance of zoonosis and the economic 
losses, which they occasionally, have been grossly underestimated or have 
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remained unknown for most countries. This stems from the lack of national 
surveillance programmes, and particularly of diagnostic facilities. 
 In Sudan most estimates of economic losses caused by brucellosis have 
been based on a combination of common sense and limited information. The 
greatest prevalence in Sudan is found in dairy cattle. The highest losses in 
terms of decreased milk yield to about 50% late abortion causes a reduction of 
about 20-30% and even infected cows which appear to calve normally suffer a 
reduction of about 7-10% (Dafaalla, 1962).  
1.15 Bioterrorsim of brucellae 
The Centers for Disease Control and Prevention lists Brucella as a possible 
bioterrorist agent; however, it has never been successfully used in this manner. 
(Centers for disease control and prevention, CDC, 2002). The centers also 
classified B. abortus, B. melitensis and B. suis as “agents of mass destruction” 
and as category B organisms. Given the ease of aerosol transmission of 
Brucella species, researchers attempted to develop it into a biological weapon 
beginning in 1942. In 1954 it became the first agent weaponized by the old US 
offensive biological weapons program.  Field-testing on animals soon 
followed. By 1955, the US was producing B. suis-filled cluster bombs for the 
US Air Force at the Pine Bluff Arsenal in Arkansas. B melitensis actually 
produces more severe disease in humans. Development of brucellae as a 
weapon was halted in 1967, and   President Nixon later banned development of 
all biological weapons on November 25, 1969. Although the Brucella 
munitions were never been used against human targets, the research performed 
resulted in concern that Brucella species some day may be used as a weapon 
against either military or civilian objectives. Brucella spp. has a high 
probability for use in biologic terrorism and are highly infectious via the 
aerosol route. It is estimated that inhalation of only 10-100 bacteria is sufficient 
to cause disease in man. The relatively long and variable incubation period (5-
60 days) and the fact that many infections are asymptomatic under natural 
conditions has made it a less desirable agent for weaponization, although large 
aerosol dosage may shorten the incubation period and increase the clinical 
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attack rate. Most cases result from travel or from ingestion of unpasteurized 
milk products. The incubation period varies from less than 1 week to several 
months, but most patients become ill within 3 to 4 weeks of exposure 
(Louisiana Office of Public Health, 2004) 
1.16 Bovine brucellosis in Sudan 
 Bovine brucellosis was proved to be endemic in the Sudan. B.abortus 
was isolated for the first time by Bennet in 1943 from a dairy farm in 
Khartoum province. Several reports of abortion were received from various 
regions during the period 1944-1952. Daffaalla and Khan, (1958) revealed 
26% prevalence rate in Barakat in the Gezira area. In 1956 brucellosis was 
diagnosed in dairy farm at Juba with prevalence  rate of 55%. In 1957 the 
disease was diagnosed in Elobied and Nuba Mountains (Dafaalla and Khan, 
1958). During 1958-59 positive results were obtained from milk and serum 
samples collected from Nisheshiba and Umbinein (Dafaalla, 1962). Elnasri, 
(1960) reporded the disease in Upper Nile province with 15% prevalence rate. 
3% positive result was obtained by Abdulla (1966) in Halfa District. Mustafa 
and  Nur (1968) obtained positive results in Gash and Tokar Districts of 
Kassala Province in Eastern Sudan. In 1969; the survey  of Kenana cattle 
conducted by Mustafa and Hassan (1969) in the Fung District, Blue Nile 
province revealed positive results. Ibrahim and Habiballa (1975) revealed 
positive results from milk samples collected from twenty three herds in 
western Sudan. Habiballa et al., (1977) examined 2720 cows from three herd 
in Khartoum, four herds in El Gazira and two herds in Blue Nile province and 
revealed positive results from the three herds of Khartoum, the Four herds of 
the Gezira and one herd from the Blue Nile. Bakheit, (1981) obtained positive 
results from cross-bred and native cattle  in El Gezira. Shallali et al.,  (1982) 
reported eleven  positive samples out of 124 milk samples from adairy farm in 
Blue Nile. Suliman, (1987) investgated the prevalence of disease in Khartoum 
and El Gazira, where the prevalence was 15.2% in the two  regions. Gameel et 
al.,  (1987) diagnosed the disease in nine out of twenty dairy herds in 
Khartoum.  In Southern darfur , Musa (1995) reported 20% positive reactivity 
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out of 1040 heads. Recently Suliman (2006) reported the diseae to be prevailed 
in Khartoum state but frequently in Khartoum North, where the current study 
was carried out. 
1.17 Human brucellosis in Sudan 
 Nomads and occupationals namely veterinary staff, abattoir and 
butchers-house workers were found to be most affected with the disease Musa, 
(1995). The disease was diagnosed in humans in Berber in the Sudan Since 
1904 (Haseeb, 1950). In 1908, Bousefield reported a case of Malta Fever. In 
the same year 20 cases were reported (Simpson, 1908). 19 of which were 
clincally diagnosed at Roseires (Blue Nile province) and one at Kassala. The 
data given by Hasseb, (1950) between the year 1925 and 1942 gave a total 
record of 920 human cases with occurrence in every one of the eighteen 
provinces. The geographical distribution included all nine province of the 
Sudan. Medical reports between the year 1928 and 1937 showed the occurrence 
of  311 human cases and the distribution of the disease was in all the nine 
provinces of the Sudan (Dafaalla, 1962). The organism was isolated from man 
(Erawa, 1966). In 1982, the Sudan medical report showed 242 cases of human 
brucellosis. In 1994, AL- Sharif obtained positive results from abattoir workers 
in Umdurman city slaughter house. In a country where hospital service, 
particularly where animal abide, is scarce and where fever is “just a fever” its 
highly likely that the difference between the actual incidence and the recorded 
one may be highly significant.  
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Chapter two 
Materials and methods 
      2.1 Study area 
Kuku Dairy Co-operative Scheme (Khartoum state) 
 Kuku Scheme is based on the famous dairy campus where local 
traditional producers have been banded together and the production of milk 
under modern hygienic conditions was established. The whole Scheme was 
established in November 1963 on the nucleus of small milk producers co-
operatives dated from 1953. 
 The Scheme covers an area of about 2600 acres of flat leveled land 
stretching out from the old riverain cultivation area on the Blue Nile banks, 
south of Khartoum North. At either end of the area, there is a large Dutch barn 
type structure in which the cows are milked under the supervision of plant 
officials. The whole project was established by American Aid and is the 
responsibility of the Department of Animal Resources in the Khartoum State 
Ministry of Agriculture. Kuku Dairy Co-operative Scheme was established in 
accordance to the Co-operatives Ordinance of 1948. The scheme is sited in 
Khartoum North, Khartoum State, Sudan. There are at present five such co-
operatives in the scheme. The objective of the co-operatives is to settle semi-
nomadic animal owners in a newly irrigated land to concentrate on the 
production of pasteurized milk (Nagat, 1982). Each farmer was allotted 10 
feddans of leased Government Land and is required to supply 52 litres of milk 
daily.  
2.2 Study subjects  
 Human subjects included all people working in the study area. Animal 
subjects include all adult raised animals in the randomly selected holdings 
(farms) within the Kuku Dairy Co-operative Scheme.  
2.3 Study design  
Descriptive cross-sectional study was applied to carry out this work.  
Prevalence of brucellosis 
  
2.4 Sample size  
2.4.1 Bovine samples  
 Based on Robinson (2003) the number of holdings, which constitute the 
primary statistical units investigated were calculated according to the following 
formula:   1/n = 1/nX + 1/N                                                                             
Where:  nX = was the sample size tabulated; n = Sample size (to be calculated) 
and N = Total number of holdings.  
 The list of the farms (holdings) was obtained from the Agriculture 
Department, Kuku Scheme Headquarter. From which random selection of holdings 
was drawn, resulting in 30 farms to be investigated. Venous blood samples were 
collected from 566 cattle and 185 milk samples from RBPT positive ones for 
culture.  Abortion materials including two vaginal swabs, one specimen of a retained 
placenta and an aspirate from a hygroma of a knee joint were also collected for 
culture.   
2.4.2 Human samples 
 A total of 176 individuals were sampled based on their willingness to 
participate in the study..  
2.5 Data Collection methods  
2.5.1 Instruments (Questionnaire and master sheet)  
 A master sheet was designed for human data and a questionnaire for bovine 
brucellosis data for each holding (Appendix 1). The master sheet included 
information about: age, sex, occupation, level of education, residence, marital status, 
previous illness, symptoms, possible sources of infection, work nature and 
nutritional habits. The information obtained from each cow were: age, breed, history 
mastitis, endometritis, retention of placenta and history of abortion and vaccination. 
2.5.2 Samples collection  
2.5.2.1 Human blood  
 Two samples of venous blood were collected aseptically from patients 
presented with symptoms compatible with brucellosis. Using sterile disposable 
syringes 10 ml blood were collected for culture and 5ml volume of venous 
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blood for serum samples, the latter blood samples were left to clot with 
minimum shaking and transported to the laboratory, refrigerated overnight, 
centrifuged, and serum samples collected from them were stored at -200C until 
tested. 
2.5.2.2 Bovine milk 
 Using sterile gloves, milk was collected from each selected cow from all 
quarters. The whole udder was washed and dried and the end of each teat 
disinfected with a swab of alcohol and wiped dry. Discarding the first one or 
two streams, 20-ml milk volumes (5ml from each teat) were collected into a 
labelled and sterile container. Contact between milk and milkers' hands was 
avoided as much as possible. The milk samples were placed immediately into 
an ice box and sent to the laboratory as soon as possible where they kept at -20 
C0 until cultured.  
2.5.2.3 Hygroma fluid 
 For collection of aspirate from the hygroma of a knee joint, the area of 
skin over the hygroma was washed with soap, hair was shaved and the surface 
of the skin rubbed with cotton alcohol swab, let to dry and disinfected with 
tincture of iodine. Using sterile disposable syringe a 20-30 ml of the hygroma 
fluid was withdrawn, kept in an ice box and submitted to the laboratory for 
bacteriological examination.  
2.5.2.4 Placental specimens 
 From cases of retained placentae specimens were collected placed into 
sterile plastic container, put in an ice box and sent to the laboratory for 
examination. 
2.5.2.5 Vaginal swabs 
 Vaginal swabs were taken from cows with retained placentas and recent 
abortion. The swabs were taken from the inner wall of the vagina by the aid of 
vaginascope. The swabs were placed into thermo-flask containing ice and 
submitted to the laboratory for bacteriological examination. Samples collected 
were processed according to Alton et al., (1975).  
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2.6 Diagnosis of brucellosis 
2.6 Bacteriological methods 
2.6.1 Culture media 
 Thayer Martin medium (TM), Serum Dextrose agar (SDA), Christensen' 
medium (CM), Tryptone soy broth (TSb) and Muller Hinton agar (MHA) were 
prepared according to the manufacturers' instructions (Appendix 2). 
2.6.2 Culture methods  
2.6.2.1 Blood 
 The 10ml blood samples were inoculated immediately after collection 
into Thioglycolate Broth bottles, incubated at 370 C under 10% CO2 tension for 
at least three weeks, while subcultures were performed on SDA on three days 
intervals. 
2.6.2.2 Milk 
 Milk samples were centrifuged at 3400 revolution per minutes (rpm) for 
15 minutes. TM plates were inoculated in duplicates by smearing the sediment 
and the cream of each samples separately or mixed over the surface of the 
medium using sterile cotton swab. The plates of each sample were incubated at 
370C one aerobically and the other under 10 % CO2 tension for 2-5 days and 
examined for growth.  
2.6.2.3 Animal tissues 
 Placental specimens from aborted cows were sliced using sterile scissors 
and inoculated on TM medium plates by rubbing the cut surface over the 
surface of the medium. Each specimen was inoculated in two plates. The plates 
were incubated at 370C one aerobically and the other under 10% CO2 tension 
for 2-5 days and examined for growth.  
2.6.2.4 Vaginal swabs 
 The vaginal swabs obtained from recently aborted cows were used to 
prepare slide smears, stained by modified Zihel-Neelsen stain and examined 
microscopically. The positive ones were inoculated on two plates of TM 
medium, incubated at 370C, one plate in an atmosphere of 10% CO2 and the 
other aerobically for 2-5 days and examined for growth.  
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For cultures above CO2 was supplemented by using candle jar. 
2.6.3 Identification of brucellae 
 Isolates resembling brucellae were identified to species and biovar level 
according to Corbel and Hendry (1983). All procedures were carried out under 
biological safety cabinet type II. 
2.6.3.1 Primary identification 
 Brucella-like isolates were checked for identity according to their 
morphological, cultural, and antigenic properties as follows: 
2.6.3.2 Staining of the organism 
 Two different stains were used to examine slide smears from the 
presumptive organisms. Those were Gram stain (Preston and Morrell, 1962) 
and Stamp's modifies Ziehl-Neelsen method (Stamp, 1950). Smears were 
stained and examined microscopically under the oil immersion objective lens. 
2.6.3.3 Test for Brucella auto-agglutination 
 Suspension of each isolate was made by emulsifying its cultures a 0.1% 
w/v acriflavine in glass slides and examined for agglutination. 
2.6.3.4 Motility test 
 Cultures were used to inoculate two tubes of Albimi brucella broth. One 
tube was incubated at 370C and the other tube at 220C both under atmosphere 
of 10% CO2. After 24-48 hours incubation the two preparations were examined 
for motility.  
2.6.3.5 Biochemical tests 
2.6.3.5.1 Oxidase test  
 A loopful of a culture from colonies of each isolate was streaked on 
filter papers pre-impregnated with oxidase reagent (1% tetramethyl-p-
phenylenediamine) and observed for development of a purple colour within 10 
sec of inoculation.  
2.6.3.5.2 Catalase test 
 The test was used to identify catalase producer isolates by mixing 
colonies of each isolate with 3% hydrogen peroxide and observed for release of 
oxygen bubbles  
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2.6.3.5.3 Methyl red test 
 Test cultures were inoculated in glucose-peptone medium and incubated 
at 370C for 48 hours under 10% CO2 tension. Two drops of 0.04% methyl red 
were added and observed for colour change to red or yellow. 
2.6.3.5.4 Voges-Proskauer reaction 
 This test was performed after completing the methyl red test. Amounts 
of 0.2ml of 40% (w/v) ethanolic α-naphthanolic solution and 0.2ml of 40% 
(w/v) of KOH, were added and mixed well and examined after 15 minutes and 
one hour for development of a red colour.  
2.6.3.5.5 Citrate utilization test 
 Cultures of the isolates were inoculated in Koser's citrate medium and 
incubated at 370C for 48 hours under 10% CO 2 tension. Utilization of citrate as 
a source of carbohydrates was indicated by appearance of turbidity. 
2.6.3.5.6 Indole test 
 Isolates were inoculated on glucose-peptone water and incubated for 
five days at 370C under 10% CO 2 tension. Then 0.5ml of Kovacs' reagent was 
added, shaked for one minute and observed for development of a red colour in 
the surface layer within ten minutes. 
2.6.3.5.7 Nitrate reduction 
 This test was performed by inoculation cultures of each isolates on 
nitrate broth medium and incubated for five days at 370C. Addition of 1ml of 
0.8 % sulphanilic acid in 5mol/litre acetic acid followed by the addition of 1ml 
of 0.5% α-naphthylamine in 5mol/litre acetic acid and observed for 
development of red colour within five minutes.  
2.6.3.5.8 Glucose fermentation and gas production 
 Cultures were inoculated into glucose-peptone water and incubated for 
five days at 370C under 10% CO 2 tension and observed for acid or gas 
production. 
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2.6.3.5.9 Gelatin liquefaction  
 Test isolates were inoculated on gelatin stabs and incubated at 40C for 
14 days under 10% CO 2 tension and observed for gelatin liquefaction after 14 
days. 
2.6.4 Typing of brucellae to the genus and biovar levels 
 Isolates identified as Brucella strains based on the primary examinations 
mentioned were typed to the species and biovar level by the: FAO/WHO 
Collaborating Centre for Reference and Research on Brucellosis, UK 
according to the procedures of Corbel and Hendry (1983) as follows:  
2.6.4.1 Agglutination with Monospecific antisera 
 Drops of A , M and R/C Brucella monospecific antisera were placed 
separately on clean glass slides. Similar drops of each Brucella isolate 
suspended in sterile distilled water were added to each drop of the antiserum. 
The drops were mixed for about one minute and examined for agglutination.   
2.6.4.2 Production of hydrogen sulphide 
 Lead acetate strips were hanged over SDA slope culture of each isolates 
and incubated at 370C in an atmosphere of 10% CO2 for 72 hours and observed 
for blackening of lead acetate strips. 
2.6.4.3 CO2 requirements  
 This was determined by incubating each Brucella strains in two identical 
plates at 370C, one incubated in air and the other incubated under 10% CO2 
tension.  After 72 hours incubation, growth on the plates incubated in air 
indicated negative CO2 requirement.  
2.6.4.4 Growth on dye plates  
 The dyes basic fuchsin at a final concentration of  20µg/ml, thionin at 
20µg/ml and Safranin O at 100µg/ml in SDA were used for dye sensitivity tests 
. After the medium was set, the plates were incubated overnight to be checked 
for sterility. Suspensions of Brucella cultures under test were prepared by 
emulsifying a loopful of each test culture in 1.0 ml sterile normal saline. A 
loopful of each suspension was used to make five streakings for each test 
strain. Up to four isolates per plate were tested. The plates were incubated at 
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370C under 10%CO2 tension for 3-5 days and read for growth. Test Brucella 
isolates were considered resistant to the dye when growth occurred in three 
streaks or more, and considered sensitive when growth occurred in less than 
three streaks.    
2.6.4.5 Urease production (Christensen's method) 
 Slopes of Christensen's urea agar were inoculated with a loopful of the 
test Brucella cultures and incubated at 370C. The slopes were examined after 
15 minutes, one hour, two hours and 18 hours. Positive reaction was indicated 
by pink colour development or otherwise the reaction is considered negative. 
2.6.4.6 Phage sensitivity 
 Isolates were tested for lysis by phages: Tbilissi (Tb), Weybridge (Wb), 
Frenzi (Fi), Berkley (Bk), Izantagar (Iz) and Rough phages (R). A loopful of 
suspension of each isolate was inoculated on SDA plate to produce an area of 
confluent growth. Then drops of phage suspensions at routine test dilution 
(RTD) were placed on the inoculated plate as shown in figure (2-1) below. The 
plates were left undisturbed for one hour to allow the phages to be adsorbed, 
then incubated at 370C in an air + 10% CO02 for 48-72 hours and examined. 
Results were reported as complete lysis (CL ), incomplete lysis (IL) or no lysis 
(NL).  
 
 
 
 
 
 
 
 
 
 
 
                         FIG. 1. Inoculation of brucellae with phages 
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2.6.5 Brucella antimicrobial susceptibility testing 
 Antibiotic-impregnated discs were used to test the susceptibility of 
Brucella isolates to different antimicrobials. The methods performed were 
those recommended by the National Committee for Clinical Laboratory 
Standards NCCLS, (1997). The bacterial inoculums were prepared by making a 
direct saline suspension for the isolates and the turbidity was adjusted to 0.5 
McFarland standards as described by Jorgenson et al. (1997). MHA plates were 
prepared and inoculated using sterile cotton swabs which were dipped into the 
adjusted suspensions, pressed and rotated firmly several times in the inside wall 
of the tube above the fluid level. This was done to remove excess inoculum 
from the swabs. MHA plates were inoculated by streaking the swab over the 
entire agar surface. This procedure was repeated by streaking two more times, 
rotating each plate approximately 600 each time to ensure an even distribution 
of inoculum. Antibiotics to be tested against Brucella isolates were applied in 
sets of four discs per plate. The disks were dispensed onto the surface of the 
brucellae-inoculated MHA plates. Each disk was pressed down to ensure 
complete contact with the agar surface. Plates were incubated at 350-370 C 
under 10% CO2 tension for 48-72 hours. The antibiotics in each set were those 
most likely to be used in the treatment of human brucellosis including those 
recommended by the FAO/WHO, (1986). The concentrations used were 
measured in µg and shown in the subscripts of each antibiotic abbreviation 
below. The antibiotics used were: Aminoglycosides (streptomycin S300), 
Tetracycline (Doxycycline DO30 ), Rifampicin (RD5), Flouroquinolones 
(Ciprofloxacin CIP5), Cephalosporins (ceftriaxone CRO30), Penicillin 
(Ampicillin A10), (Chloramphenicol C30) and Co-trimoxazole (trimethoprim 
/sulfamexazole SXT25). For quality control, standard reference strains were 
used. These were the E. coli ATCC (25922), Staphylococcus aureus ATCC 
(25923) and B. abortus S19 (Akova et al. 1999). The inhibition zone diameter 
was measured (using a millimeter ruler) and interpreted according to 
Jorgenson, (1997).  
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2.7 Serological tests 
2.7.1 Milk Ring Test (MRT). 
 Milk samples were mixed thoroughly to disperse the cream evenly and 
1ml from each sample was transferred into sterile test tube. One drop 0.03ml 
of Ring Test Antigen (provided by the Central Veterinary Research 
Laboratories, Soba, Sudan) was added, mixed gently by shaking and inverting 
the tube several times. The mixture was incubated for one hour. The test was 
considered positive if the intensity of the blue (Haemotoxylin) colour in the 
cream layer was deeper than in the skim portion, and was considered negative 
if the intensity of the blue colour in the cream layer was equal or less than in 
the skim portion. The positive milk samples were further investigated for the 
presence of Brucella organisms. That was done by inoculation of the pellet 
and/or the cream of the milk in the appropriate culture media. 
2.7.2 Rose Bengal Plate Test (RBPT) 
 Standardized buffered Rose Bengal stained antigen (provided by the 
Central Veterinary Research Laboratories, Soba, Sudan) was used to screen all 
obtained sera. The test was performed as follows: -  
i) The serum samples and antigen were brought to room temperature  (22 ± 
4°C);  
 ii) Thirty µl amount of each serum sample was placed on a white tile, enamel or 
plastic plate. 
iii) After shaking the antigen bottle well, but gently, an equal volumes  of 30µl of 
the antigen was placed near each serum spot. 
iv) Immediately after the last drop of antigen was added to the plate, the serum 
and antigen were mixed thoroughly (using a clean glass or plastic rod for each 
test)  to produce a circular or oval zone approximately 2 cm in diameter. 
 v) The mixtures were agitated gently for 4 minutes at ambient temperature on a    
rocker. 
vi)  The agglutination was read immediately after the 4-minute shaking period 
was    completed. Any visible reaction was considered to be positive. 
MRT and RBPT were performed according to Alton et al. (1975). 
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2.7.3 Competitive Enzyme-Linked Immuno-sorbent Assay cELISA  
 The test was used to confirm the results of RBPT for human and bovine 
sera (Lucero, 1999). The cELISA was performed according to the manufacturer 
(Svanova Biotech- Uppsala- Sweden AB). Kits with pre-adsorbed brucella smooth 
lipopolysaccharide (S-LPS) antigen to polystyrene plates were imported from 
Svanova Biotech. The kits were first tested for validity. The following reagent 
were supplied with the kits: 
- Brucella abortus S-LPS antigen non- infectious coated microtitre plates 
(sealed and stored dry). 
- Lyophilized monoclonal antibody (mAb.). 
- Conjugate (goat anti-mouse IgG horse-radish peroxidase HRP).   
- Phosphate buffer saline - Tween Solution 20x concentrate (PBST). 
- Sample Dilution Buffer. 
- Substrate Solution- (tetramethyl- benzidinen in substrate buffer containing 
H2O2). Stored in dark. 
- Stopper Solution- Contains sulphuric acid (Corrosive). 
- Positive Control Serum containing 0.05% merthiolate. 
- Negative Control Serum containing 0.05% merthiolate. 
- Weak positive Control Serum containing 0.05% merthiolate. 
The following were provided by the National health Laboratory (NHL). 
- 5-200 µl Precision multi-channel pipette. 
- Disposable pipette tips. 
- Distilled water. 
- Microplate washer machine (Sanofi Pateur washer). 
- 1 container: 1litre for PBS- Tween.. 
- Micro- plate photometer (Labsystem). 
2.7.3.1 Preparation of the reagents 
 All reagents were equilibrated to the room temperature before use. 
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2.7.3.1.1 PBST buffer:  
 The PBST was diluted in distilled water and 500ml volumes were 
prepared by adding 25ml PBST solution to 475 ml distilled water and mixed 
thoroughly. 
2.7.3.1.2 mAb Solution 
 The freeze dried mAb was reconstituted by adding 6ml volume of the 
sample dilution buffer carefully into the bottle containing lyophilized mAb 
immediately before use. 
2.7.3.2 Test procedure 
 The samples and controls were diluted by adding them directly into the 
wells of the plates pre-filled with the buffer, this was done by: 
 - Adding 45µl amounts of dilution buffer to each well that will be used for test      
serum samples and serum controls, then: 
- Five µl amounts of serum controls added to each of the appropriate wells. 
Each control was put in duplicate. 
- Five µl amounts of sample dilution buffer were added to two appropriate 
wells (designated as Conjugate control, Cc).  
-  Five µl amounts of test sample were added to each of the appropriate 
wells. Each sample was put in duplicates. 
-  Fifty µl amounts of mAb-Solution were added to all wells used for 
controls and samples in not more than 10 minutes. The plates were sealed 
and the reagents mixed thoroughly by tapping the sides of the plate. The 
plates were incubated at room temperature for 30 minutes. Then rinsed 4 
times with PBST.  
-  Hundred µl amounts of conjugate solution were added to each well then 
the plates were sealed and incubated at room temperature for 30 minutes. 
The plates were rinsed 4 times with PBST. Rinsing procedure was 
performed using Sanofi Pasteur washer. 
-  Hundred µl amounts of the substrate solution were added to each well and 
incubated for 10 minutes at room temperature. Timing began after the first 
well was filled. 
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-  The reaction was stopped by adding 50 µl amount of the stopper solution 
in the same order as the substrate solution was added to each well and 
mixed thoroughly. 
-  Within 15 minutes after the addition of the stopper solution the optical 
densities (OD) of the controls and samples were measured at 450 nm. OD 
using a micro-plate photometer (Lab system; Finland). 
2.7.3.3 Calculations 
 The mean OD-values for each of the controls and samples were 
recorded and the percentage inhibition (PI) values for controls and samples 
were calculated using the following formula:  
  PI (Inhibition percent) = 100 -   (mean OD samples/control * 100) 
                                                     Mean OD conjugate control Cc 
2.7.3.4 Criteria for test validity 
  To ensure validity of the kits, the values of the controls must fall within 
the following limits, as designed by the manufacturer: 
            OD Cc                                         0.75-2.0 
            PI Positive Control                       90-100 
            PI Weak Positive control              35-65 
            PI Negative Control                    (-10)-15 
2.7.3.5 Interpretation 
   The status of a test is determined as follows: 
              PI                         Status 
       <    30%                      Negative 
       ≥    30%                      Positive 
2.7.4 Rapid Slide Test (RST) 
 This test was performed as described by Lucero et al., (2005), except 
that the volumes of the test serum and the antigen were raised up to 50 µl so 
that it can be read by the unaided eye. Killed and stained Brucella antigen as a 
whole cell suspension was used in this test. All obtained human sera were 
screened by this test. Briefly: Fifty µl of serum were placed in test slide, and 
then 50 µl of antigen was. Both were mixed, shacked, and read for 
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agglutination within one minute. Any degree of agglutination was considered 
as positive reaction.  
2.7.5 Tube Agglutination Test (TAT) 
 This test was used to measure the titre of human serum samples reacted 
positive to RST and RBPT. The antigen used in RST was used in this test. The 
method described by Irmak et al., (2004) was adopted with the exception the 
test was performed in test tubes instead of microtitre plates. Briefly: Serial 
double dilutions of the test serum samples were made on eight test tubes as 
follows: 
a. An amount of 1.9 ml normal saline was placed into tube no.1 and 1ml 
amounts of saline into each of the other tubes. 
b. Serum dilutions of 1: 20 were made by adding 0.1ml of the test serum 
samples to tube No.1, mixed and 1ml transferred to tube No.2 to make 1:40 
serum dilution, mixed and 1ml transferred to tube No.3 to make 1:80 serum 
dilution and so on. 
c. One ml amount was discarded form tube No.7, which containing serum 
diluted to 1:1280. Tube No.8 served as a blank control and containing only 
saline. 
d. Fifty µl of the above antigen were added to each tube; well mixed and 
incubated at 370C in water bath for 24 hours. Standard tube agglutination 
titre of 1:160 or greater was considered positive for brucellosis (Al Sekait, 
1999) 
2.8 Data management and analysis 
 Primary data collected using questionnaire and master sheet. Laboratory 
results were kept on record book and computer software programmes. The 
obtained data analysed using Statistical Package for Social Science (SPSS 
version 11.5 for Windows) and the results of the analysis were demonstrated by 
tables and charts. 
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Chapter three 
Results 
3.1 Diagnosis of brucellosis 
3.1.1 Human brucellosis 
3.1.1.1 Serological tests results 
 As shown in Table 9. the RBPT was more sensitive than the RST and less 
specific than cELISA. Four patients (2.3%)  out of the total people investigated 
and (20%) of total positive cases showed symptoms compatible with brucellosis. 
Summary of the symptoms is shown in Table 2. 
Table 9. Seroprevalence of human brucellosis. 
Total  people 
investigated  
Test used Positive  reactors Prevalence 
% 
RBT 29 16.5 
RST 28 15.9 
TAT 26 14.8 
 
176 
cELISA 20 11.4 
 
Table 10. Symptoms of people found serologically positive for brucellosis. 
Symptoms 
Frequency Percent from 
the total 
% 
Fever, headache and arthralgia. 001.0 000.6 
Fever, headache, arthralgia and night 
sweating 
001.0 000.6 
Fever, headache, arthralgia, night sweat, 
fatigue  
002.0 001.1 
Total symptomatic people 004.0 002.3 
 
3.1.1.2 Bacteriological results 
 No Brucella or other pathogenic organisms recovered from any of the 
blood samples collected from humans. 
3.1.1.3 Management of infected people 
 The patients who showed symptoms of the disease were examined by a 
physician who prescribed for each 100mg Doxycycline twice daily for 6 wks 
per oss and 1g of Streptomycin daily for 2wks parentally. The patients were 
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monitored and re-examined six months post-treatment. The post-treatment 
serology results showed positive reactions for RBT and RST but these results 
were not confirmed by TAT and cELISA (Table 11). The patients were asked 
to telephone in case of complain but no calls were received.  
Table 11. Post-treatment serological tests results for patients with active 
brucellosis. 
Test +ve reactors* -ve reactors * 
RBT 4 - 
RST 3 1 
TAT - 4 
cELISA - 4 
 
3.1.1.4 Risk factors 
 Possible risk factors for infection with brucellosis are summarized in 
table 12.  The results in the table showed that consumption of raw milk and 
handling of abortion materials were the most frequent risk factors that the study 
subjects have been exposed to. 
Table 12.  Possible risk factors for human infection 
Risk factors Frequency % No. +ve  
Consumption of raw milk 163 92.6 20(12.3%) 
Hand abrasions 77 43.8 20(13.1%) 
Handling of placentas 
and aborted foeti 
 
158 
 
89.8 
 
18(11.4) 
 
3.1.1.5 Socio-demographic data  
 Socio-demographic information considering age, sex, occupation, 
residence, , education level and knowledge about zoonoses are presented in 
tables (13-18), respectively. The results showed that the age range group 15-30 
years and males were the most affected (Tables 13-14) 
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Table 13. Age  
Table 14. Sex 
Sex  +ve* reactors Prevalence (%) within total  
Male 19 10.8 
Female 1.0 0.6 
Total  20 11.4 
 
 Based upon occupation, milkers were found to be the most frequently 
affected by the disease (Table 15). Based on residence, those who resided 
inside farms were found to be the most affected (Table 16). Moreover, 
considering education those who received education were more affected 
particularly those who declared having primary education (Table 17). 
Concerning knowledge about zoonoses, analysis of collected data showed that 
there are insignificant differences between those who had some knowledge 
about zoonotic diseases and those who did not have (Table 18).  
Table 15. Occupation 
Occupation Total  No. +ve  reactors (%)* 
Milker 120 14 (8.0) 
Farmer 25 2.0 (1.1) 
Labourers 13 2.0 (1.1) 
Veterinarians 8.0 1.0 (0.6) 
Vet. Technician 6.0 1.0 (0.6) 
Visitors 6.0 0.0  (0.0) 
Total 176 20.0 (11.4)  
  
 
 
 
Age range Frequency %  No.+ ve  % +ve from the total 
people examined  
1- 15 1.0 0.6 0.0 0.0 
16-30 116 65.9 17 9.7 
31-45 50 28.4 3.0 1.7 
> 45 9 5.1 0.0 0.0 
Total 176 100.0 20 11.4 
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Table 16. Residence. 
Residence Frequency + ve  reactors* 
Inside farm 126 14 (8.0%) 
Out side farm 50 6 (3.4%) 
Total 176 20 (11.4%) 
Table 17. Education level. 
Category  Frequ
ency  
Percent +ve* 
reactors 
%+ve* 
within 
educated 
Prevalence  
within total  
(%) 
Illiterate 42 23.9 4 9.5 2.3 
Literate 134 76.1 16 11.9 9.1 
Total  176 100.0 20 21.4 11.4 
Education 
level 
Frequency % within the 
total 
+ve * 
 
% prevalence
Primary 76 43.2 11 6.3 
Khalowa 37 21.0 2 1.1 
University 15 8.5 1 0.6 
Secondary 6 3.4 2 1.1 
Total 134 76.1 16 9.1 
Table 18. Knowledge about zoonoses 
 
In all tables above *= based on cELISA  
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+ve * 
Prevale
nce 
within 
total % 
Yes 150 85.2 Reading 16 10.7 2.0 1.1 
No 26 14.8 Hearing 110 73.3 6.0 3.4 
Vet. 
Extension 
8 5.3 0.0 0.0 
Health 
Education 
16 10.7 3 1.7 
 
 
 
 
Total 
 
 
 
 
176 
 
 
 
 
100.0 Total 150 100 11 6.2 
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3.1.2 Bovine brucellosis 
3.1.2.1 Serological results  
 Seroprevalence rates of bovine brucellosis within farms and within 
individual investigated cattle are shown in tables 11 and 12.   
Table 19. Seroprevalence rate of bovine brucellosis among individual animals. 
Total No. of 
animal tested 
RBPT % cELISA % 
566 185 (32.7%) 155 (27.4%) 
 
Table 20. Seroprevalence rate of bovine brucellosis within farms (holdings) 
Total 
No. of 
farms 
Diagnostic 
tests 
Farms with positive 
reactors 
Prevalence rate (%) 
RBPT 28 93.3  
30 cELISA 27 90.0 
  
3.1.2.2 Bovine milk samples testing results 
The results of MRT are shown in table 13.  
Table 21. Prevalence of bovine brucellosis using MRT. 
Total No. of 
animal tested 
Prevalence within milk 
samples  
Prevalence within total 
185 (163) 88.1% 28.8 % 
 
3.1.2.3 Bacteriological results 
 The results of specimens cultured are presented in table 14. As shown in the 
table only milk and hygroma aspirate were positive for culture. 
Table 22. Results of cultural examination. 
Specimen No. culture +ve (% from total) 
Bovine milk 10 (1.8) 
  Hygroma aspirate 1 (0.2) 
Vaginal swabs 0 (0.0) 
Placental tissues 0 (0.0) 
Total  11 (2.0) 
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3.1.2.3.1 Identification of isolates 
 Isolated bacteria were identified to the generic and biovar levels using 
microscopical, biochemical, serological and phage typing techniques. The 
isolates were identified as brucellae based on morphological and biochemical 
characteristics ((FIG. 4-7 and table 23). Identification of recovered brucellae to 
species and biovar levels was performed. Two of the isolates were found to be 
Brucella abortus biovar 1 and nine Brucella abortus biovar 6 (table 24).  
Table 23. Identification of isolates to generic level. 
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9 - + + + - + + - - - Brucella sp.
10 - + + + - + + - - - Brucella sp.
24 - + + + - + + - - - Brucella sp.
29 - + - + - + + - - - Brucella sp.
37 - + + + - + + - - - Brucella sp.
40 - + - + - + + - - - Brucella sp.
70 - + + + - + + - - - Brucella sp.
71 - + + + - + + - - - Brucella sp.
102 - + + + - + + - - - Brucella sp.
118 - + + + - + + - - - Brucella sp.
Hyg - + + + - + + - - -  Brucella sp.
 - = negative., + = positive., Hyg = isolate from a hygroma of a knee joint., 
M.Z = modified Ziehl-Nelsen stain.  
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FIG. 2. Shows colonies of Brucella organisms on Thayer Martin medium. 
 
  
FIG. 3. Shows gram-stain of smears prepared from a culture of Brucella 
organisms showing G-ve coccobacillary  shape 
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FIG. 4. Shows growth of Brucella organisms on SDA medium containing  
  thionin at 20µg/ml. 
 
  
FIG. 5.  Shows growth of Brucella organisms on SDA medium containing   
Basic fuchsin at  20µg/ml. 
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Table 24. Identification of the Brucella isolates to the species and biovar levels 
 
 
BF= basic fuchsin at 20µg/ml conc., TH= thionin at 20µg/ml conc., Hy = isolate 
from a hygroma aspirate., RTD = routine test dilution., CL= complete lysis., NL = 
No lysis 
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3.1.2.4 Susceptibility of Brucella isolates to some chemotherapeutic agents  
 Results of susceptibility of Brucella isolates to eight chemotherapeutics 
are shown in table 25. The isolate were found to be sensitive to all 
antimicrobials used except two isolates which were found to be resistant to 
Rifampicin.  
Table 25. Susceptibility of Brucella isolates to chemotherapeutics used for 
treatment  of the disease. 
 
Do=doxycycline.,RD=rifampicin.,STR=streptomycin.,Cip=ciprofloxacin.,C=ch
loramphenicol.,SXT=cotrimexazole(trimethoprim & sulfamethoxazole)., A= 
ampicillin., CRO= ceftriaxone., S= sensitive., R= resistant., *= ATCC 25923., 
** = ATCC 25922., 1 = isolate from a hygroma of a knee joint. 
 
 
        Antibiotic 
 
Organisms 
 Tested 
DO RD STR Cip C CRO SXT A 
S. aureus * S S S S S S S S 
E. coli ** S S S S S S S S 
B. abortus S19 S S S S S S S S 
9 S S S S S S S S 
10 S S S S S S S S 
24 S S S S S S S S 
29 S S S S S S S S 
37 S S S S S S S S 
40 S S S S S S S S 
70 S S S S S S S S 
71 S S S S S S S S 
102 S R S S S S S S 
118 S R S S S S S S 
Hy1 S S S S S S S S 
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3.1.2.5 Clinical manifestations of brucellosis  
 
FIG. 6. Shows a cow with retained placenta and found +ve for brucellosis. 
 
FIG. 7. A cow with a hygroma of the knee joint found + ve for brucellosis. 
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 3.1.2.6 Mixed farming of goats and cattle   
 
FIG. 8. Shows mixed farming of cattle and goats in the same premises. 
3.1.2.7 Cross tabulation analysis 
 Cross tabulation analysis was carried out for pathological manifestations 
and diagnostics approaches used in this study. The analysis were presented and 
demonstrated in tables (26-29) and figures (9-12). The results showed that the 
cELISA was more specific than the RBPT and MRT and that the isolation rate of 
brucellae was lesser than the seroprevalence rates obtained by the serological 
tested used.  
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Table 26. Cross tabulation between RBPT and clinical manifestations. 
RBPT path.man* occurrence 
+ ve - ve 
Total 
Count 46 44 90 
% within C.Aba 51.1 48.9 100 
%within RBPT 24.9 11.5 15.9 
 
 
 
Yes % of Total 8.1 7.8 15.9 
Count 139 337 476 
% Within C.Ab 29.2 70.8 100 
% within RBPT 75.1 88.5 84.1 
 
 
 
Cases of 
abortion  
 
No 
% of Total 24.6 59.5 84.1 
Count 63 70 133 
% within R.PLb 47.4 52.6 100 
% within RBPT 34.1 18.4 23.5 
 
       
Yes 
% of Total 11.1 12.4 23.5 
Count 122 311 433 
% within RPL 28.2 71.8 100 
% within RBPT 65.9 81.6 76.5 
 
 
Retention 
of placenta 
 
 
No 
% of Total 21.6 54.9 76.5 
Count 50 66 116 
% within masc 43.1 56.9 100 
% within RBPT 27.0 17.3 20.5 
 
Yes 
% of Total 8.8 11.7 20.5 
Count 135 315 450 
% within masc 30 70 100 
% within RBPT 73.0 82.7 79.5 
 
 
 
Mastitis  
 
No 
    
 
a= cases of abortion, b= retention of placenta, and c= mastitis, * pathological 
manifestations. 
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      Fig. 9. RBPT in cross tabulation with abortion  
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Table 27. Cross tabulation between cELISA and clinical manifestations. 
cELISA Total path.man* occurrence 
+ ve - ve  Non **  
Count 40 6 44 90 
% within C.Aba 44.4 6.7 48.9 100 
% within cElisa 25.8 20.0 11.5 15.9 
 
 
 
Yes % of Total 7.1 1.1 7.8 15.9 
Count 115 24 337 476 
% within C.Ab 24.2 5.0 70.8 100 
% within 
cELISA 
74.2 80.0 88.5 84.1 
 
 
 
Cases of 
abortion  
 
No 
% of Total 20.3 4.2 59.5 84.1 
Count 54 9 70 133 
% within R.PLb 40.6 6.8 52.6 100 
% within 
cELISA 
34.8 30.0 18.4 23.5 
 
       
Yes 
% of Total 9.5 1.6 12.4 23.5 
Count 101 21 311 433 
% within R.PL 23.3 4.8 71.8 100 
% within 
cELISA 
65.2 70.0 81.6 76.5 
 
 
Retention of 
placenta 
 
 
No 
% of Total 17.8 3.7 54.9 76.5 
Count 43 7 66 116 
% within mastc 37.1 6.0 56.9 100 
% within 
cELISA 
27.7 23.3 17.3 20.5 
 
Yes 
% of Total 7.6 1.2 11.7 20.5 
Count 112 23 315 450 
% within mastc 24.9 5.1 70 100 
% within 
cELISA 
72.3 76.7 82.7 79.5 
 
 
 
Mastitis  
 
No 
% of Total 19.8 4.1 55.7 79.5 
 
*= pathological manifestations., ** test  was not done., a= cases of abortion., 
b= retention of placentae., and c= mastitis. 
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Fig. 10. cELISA in cross tabulation with retention of placenta. 
   NB. Non= test was not done 
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        Table 28. Cross tabulation between MRT and clinical manifestations. 
MRT Total path.man* occurrence 
+ ve - ve Non **  
Count 44 2 44 90 
%within C.Aba 48.9 2.2 48.9 100 
% within MRT 27.0 9.1 11.5 15.9 
 
 
 
Yes % of Total 7.8 .4 7.8 15.9 
Count 119 20 337 476 
%within C.Aba 25.0 4.2 70.8 100 
% within MRT 73.0 90.9 88.5 84.1 
 
 
 
Cases of 
abortion  
 
No 
% of Total 21.0 3.5 59.5 84.1 
Count 57 6 70 133 
% within R.PLb 42.9 4.5 52.6 100 
% within MRT 35.0 27.3 18.4 23.5 
 
       
Yes 
% of Total 10.1 1.1 12.4 23.5 
Count 106 16 311 433 
%within R.PLb 24.5 3.7 71.8 100 
%within MRT 65.0 72.7 81.6 76.5 
 
 
Retention 
of placenta 
 
 
No 
% of Total 18.7 2.8 54.9 76.5 
Count 46 4 66 116 
% within mastc 39.7 3.4 56.9 100 
% within MRT 28.2 18.2 17.3 20.5 
 
Yes 
% of Total 8.1 0.7 11.7 20.5 
Count 117 18 315 450 
% within mastc 26.0 4.0 70.0 100 
% within MRT 71.8 81.8 82.7 79.5 
 
 
 
Mastitis  
 
No 
% of Total 20.7 3.2 55.7 79.5 
 
 * = Pathological manifestations. **= test was not done., a= cases of abortion., 
 b= retention of placenta., and c= mastitis. 
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            Fig. 11. MRT in cross tabulation with mastitis. 
                NB. Non= test was not done 
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 Table 29. Cross tabulation between culture and clinical manifestations. 
culture Total path.man* occurrence 
+ ve - ve Non **  
Count 10 34 46 90 
%within C.Aba 11.1 37.8 51.1 100 
%within 
culture 
100 22.2 11.4 15.9 
 
 
 
Yes 
% of Total 1.8 6.0 8.1 15.9 
Count 0 119 357 476 
%within C.Aba 0.0 25.0 75.0 100 
%within 
culture 
0.0 77.8 88.6 84.1 
 
 
 
Cases of 
abortion 
 
 
No 
% of Total 0.0 21.0 63.1 84.1 
Count 10 46 77 133 
%within R.PLb 7.5 34.6 57.9 100 
%within 
culture 
100 30.1 19.1 23.5 
 
       
Yes 
% of Total 1.8 8.1 13.6 23.5 
Count 0 107 326 433 
%within R.PLb 0.0 24.7 75.3 100 
%within 
culture 
0.0 69.9 80.9 76.5 
 
 
Retention of 
placenta 
 
 
No 
% of Total 0.0 18.9 57.6 76.5 
Count 10 36 70 116 
% within mastc 8.7 31.0 60.3 100 
%within 
culture 
100 23.5 17.4 20.5 
 
Yes 
% of Total 1.8 6.4 12.4 20.5 
Count 0 117 333 450 
%within mastc 0.0 26.0 74.0 100 
%within 
culture 
0.0 76.5 82.6 79.5 
 
 
 
Mastitis  
 
No 
% of Total 0.0 20.7 58.8 79.5 
 
 * Pathological manifestations., **= Test was not done., a= cases of abortion., 
 b= retention of placenta., and c= mastitis. 
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 Fig. 12. Cross tabulation between culture positive cases and     
     abortion  
                         
 
 NB. Non= test was not done 
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Chapter four 
 Discussion 
 
 Brucellosis is a worldwide zoonotic disease (Boschiroli et al., 2001). 
Several studies were carried out on brucellosis in Sudan but most of them were 
directed towards the disease in the animal host (e.g. Bennet (1943); Daffalla 
and Khan (1958); Suliman (1987); Habiballa et al., (1977); Musa and Jahans, 
(1990) and Suliman, (2006)). While the disease in humans was not extensively 
studied. The present study included both animals and humans in the Kuku 
Dairy Scheme area.  
 Diagnosis of human brucellosis was done based on symptoms, isolation 
of brucellae and serum testing. The RBPT and RST were used as screening 
tests, while cELISA was used for confirmation and TAT for titration. The 
limitations of TAT i.e. prozone phenomenon, time consuming and failure to 
differentiate cross reacting antibodies made it less preferable. In contrast, 
cELISA was used as the mainstay confirmatory tests, for its ability to 
overcome the limitations of TAT (Lucero, 1999). 
 Considering human brucellosis, the results of the present study showed 
seroprevalence rates of 11.4% and 14.8 % based on cELISA and TAT, 
respectively (Table 9). Comparatively the prevalence of the disease among 
patients having active infection was found relatively to be lower (2.3%, Table 
10). These findings are approximately similar to those obtained by Musa 
(1995) among nomadic tribes in Southern Darfur and those reported by Al 
Sharif (1994) among slaughterhouse workers in Omdurman, where 12.7% and 
10 % of the investigated population were found to be seropositive, 
respectively. However, Villamarin-Vazquez et al., (2002) in Spain reported 
different ones (3.1% seroprevalence). These findings are not dissimilar with 
those of the current study. This may be due to the different diagnostic tests 
used, and to other factors such as the size of the problem in the contacted 
animal reservoir and the awareness of the target population in each country. 
Furthermore, the findings considering patients who had have an active disease 
and asymptomatic seropositive reactors are similar to those of Alballa, (1995) 
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in southern Saudi Arabia, who reported that 2.3% of the people examined were 
found to have an active disease, while 19.2 % of them were asymptomatic with 
serological evidences of exposure. Having asymptomatic seropositive reactors 
in the study area could be due to the long exposure to brucellae possibly sub-
doses, and hence acquiring some kind of resistance. This long exposure could 
be attributed to the status of the Kuku area as being endemic with brucellosis 
for along time without control (Suliman, 1986). This view is in agreement with 
that of Awad, (1998) who concluded that immunity to brucellae is sometimes 
observed in populations where brucellosis is endemic and a significant 
proportion of the population are serologically positive without showing any 
symptoms. In addition, he stated that such people, being frequently exposed to 
brucellae, acquired some kind of immunity, which could be boosted by 
repeated contact. Furthermore, the patients having active infection were treated 
and reexamined six months post treatment for relapses. Despite the positive 
results obtained by screening tests for those patients, none of them was 
confirmed by cELISA or TAT (Table 11). The findings considering persisted 
antibrucella antibodies detected by the screening tests are acceptable since that 
antibrucella antibodies can persist in brucellosis patients even after successful 
treatment (Farrel, 1996). These findings are in agreement with those of Maha 
et al., (2002) who reported similar persistence in patients with acute brucellosis 
after receiving effective and successful treatment. Such findings gain 
importance by posing challenge for the diagnosis of brucellosis when such 
patients admitted with signs and symptoms suggestive for brucellosis but 
actually they are due to other pathogens. 
 Trials were attempted to recover brucellae from blood samples collected 
from symptomatic cases, but all were not successful. This could be attributed 
to the chronic phase of the disease during which sampling was occurred. It was 
previously proved that brucellae tend to localize in the reticulo-endothelial 
organs and rarely found in the circulating blood during the chronic phase of the 
disease (Farrell, 1996). Nevertheless, we believe that the recovered B. abortus 
strains isolated from milk of the cattle in the study area are the most probable 
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etiology of human brucellosis cases  in Kuku and possibly other areas in 
Khartoum State..  
  The risk factors such as consumption of raw milk, hand abrasions and 
handling of abortion materials were found to be the most important factors for 
infection (Table 12). These findings are in agreement with those of Huber and 
Nicoletti, (2000) and Zowghi et al.,(1992), who concluded that consumption of 
raw milk poses potential hazard for human health, particularly for transmission 
of brucellae. It wroth mentioning that, meeting the demand for pasteurized 
milk supply for the general population is one of the objectives of the 
establishment of the Kuku scheme. However, this is no longer committed to for 
the time being. And milk is sold freely for the public despite the potential 
hazards that may arise.   
 Considering demographic data, increased susceptibility to infection 
associated with sex and age in the present study (Tables 13-14) is not 
acceptable due to the fact that humans are susceptible to Brucella infection 
regardless of sex, age and ethnicity (Farrell, 1996). The increased susceptibility 
to brucellae observed in the present study in respect to age and sex could be 
attributed to reduced number of females and young people (due to tough work 
in dairy farms) compared to the number of the most affected people i.e. men 
within the age range 15-30 years. This reduction in number might have made 
children and females less exposed and consequently less affected. Moreover, 
increased susceptibility to brucellosis was also observed among those at high 
risk occupationally linked to cattle and who reside inside farms and also among 
those of lower education and have no information about zoonotic diseases 
(Tables 15-18). These findings we believe are attributable to increased 
exposure. It is interesting that these findings are comparable to those reported 
by Awad, (1998) from Palestine, Salari (2003) from Iran, Al-Ani (2004) from 
Jordan, Atmaca (2004); and Cetinkaya (2005) from Turkey and Sera and Viňas 
(2004) from Spain. They concluded that agricultural workers are relatively at 
high risk for infection with brucellosis. And health education beside veterinary 
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extension are important tools to raise the awareness of these groups about the 
danger of the disease in question.   
 Bovine brucellosis was diagnosed by means of serological tests i.e. 
RBPT, cELISA and MRT (Tables 19-21), clinical manifestations of the disease 
(Fig. 6-7) and isolation of brucellae (Table 22). The prevalence rates of bovine 
brucellosis in the current study were 27.4%, 32.7% and 28.8% based on 
cELISA, RBPT and MRT, respectively. All RBPT positive samples could not 
be confirmed in the present study. This might be due to cross-reacting 
antibodies, since the cELISA is capable of differentiating antibodies due to 
infection with brucellae from those due to antigenically related pathogens 
(Lucero, 1999). According to Nakavuma (1994) the RBPT provides more 
likely false positive results than to miss brucellosis. The prevalence rates in the 
present study were slightly lower than those reported by Suliaman, (2006) who 
used the same serological tests except cELISA. Instead, he used iELISA. His 
results showed that the prevalence rates of the disease in Khartoum North to be 
34%, 35.1% and 42.8%. But he found them to be 26.8%, 24.3% and 37.1% in 
Khartoum, and 20%, 12.9% and 29.8% in Omdurman city based on RBPT, 
iELISA and MRT, respectively. As a result the disease seems to be more 
prevalent in Khartoum North than in the other two cities. This could be due 
comparatively to the great number of animals raised in Khartoum North. In 
addition, the absence of controlled animal movement could have played an 
important role in the spread of the disease. The findings of the present study 
considering farm prevalence come in agreement with those of Bakheit, (2004) 
who reported farm prevalence rate  approaching 100% in Khartoum state. The 
results are also in agreement with those of Asfaw, (1997) in the pre-urban dairy 
production systems around Addis. These findings confirmed the ability of 
brucellae to spread farm animals after getting access  
 The milk from 1.8% (Table 22) of the MRT positive reactors in the 
study area yielded positive culture results. The milk from the study area is 
distributed untreated for the public in the Khartoum State. This fact calls for an 
urgent investigation of the incidence of brucellosis among the general 
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population. In addition, strict regulations concerning safety of the milk and 
milk product as being free of brucellae should be implemented. The results of 
identification of isolated brucellae to the species and biovar levels revealed that 
Brucella abortus biovar 6 and Brucella abortus biovar1 as the causative 
organisms. These findings are similar with those of Musa, (2001) who reported 
that Brucella abortus biovar 6 as the common cause of bovine brucellosis in 
the Sudan. However, the existence of Brucella abortus biovar1 as an other 
cause raised epidemiological concerns about its sources and susceptibility to 
chemotherapeutics in use. But due to logistic obstacles and lack of sufficient 
information about the origin of the source animals hindered tracing procedures. 
 The present study showed that the majority of the isolates examined 
were inhibited by chemotherapeutics used. However, two of them (18.2%) 
showed in vitro resistance to Rifampicin at the concentration used (Table 25). 
This resistance is unusual and needs to be scrutinized in depth a matter which 
is beyond our capacity. Studies concerning susceptibility testing were rarely 
carried out in Sudan. Nevertheless; Musa, (2001) reported that 81% of the 
tested brucellae isolated from different parts of the Sudan were found to be 
resistant to Ampicillin. Despite the disagreement with the findings of our 
study, this might be due to the characteristics of the organism isolated from 
different localities. Hall and Manion, (1970) tested in vitro susceptibility of 
Brucella spp. to representative antibiotics in use. With regards to Brucella 
abortus, the found similar findings to those of our study against the same 
battery of antibiotics used. Furthermore, Maurin and Raoult, (2001) disputed 
over the general feeling that Aminoglycosides are poorly effective in treating 
infections due to intracellular pathogens, because of their poor ability to 
penetrate the eukaryotic cell membrane. Depending on clinical experience, 
they reported that these antibiotics are valuable therapeutic alternatives for 
infections due to intracellular pathogens, including brucellae. The current 
study confirmed that Aminoglycosides (especially streptomycin) are still 
effective against brucellosis. A reported data indicated that the susceptibility of 
brucellae to antibiotics has, with few exceptions, remained stable over decades 
Prevalence of brucellosis 
  
(Ariza et al., 1986). However, the question of the development of resistance is 
of particular interest for patients relapsing after Rifampicin treatment with 
regards to the emergence of rifampicin-resistant Brucella variants observed in 
in-vitro studies (Corbel, 1976a). 
 The clinical manifestations reported in the present study showed low 
rates of abortion 15.9%, retention of placenta 23.5% and mastitis 20.5% 
(Tables 26-29 and fig. 9-12). An average of 7.7%, 10.2% and 8.2% of those 
manifestations were found to be due Brucella infection. The low rates could be 
due to the resistance acquired by animals in Kuku area, because of the long 
history of the disease in it (Suliaman, 1987). This explanation could be 
weighted with that concluded by Dafaalla and Khan, (1958). Who reported that 
short horn type Zebu cattle are more resistant to Brucella infection than 
upgraded dairy cattle with foreign blood. However, Habiballa et al., (1977) 
attributed the low rate of abortion found within local cattle breeds, upgraded 
with Friesian blood, to the relative immunity acquired from vaccination with B. 
abortus strain 19.   
 Mixed farming between goats and cattle in the same premises was 
observed in the study area (Fig. 8). It was borne to our mind that these goats 
were not tested for brucellosis and the owner refused their sampling. These 
goats were imported from Syria and they were not recognized as a herd free 
from brucellosis due to lack of pre-importation certificates. If they were 
infected by B. melitensis consequent transmission to cattle is not unlikely 
although the organism could not be isolated. Reports showed that brucellosis 
due to B. melitensis emerged as a new bovine-related public health problem 
since that this pathogen is capable of colonizing the bovine udder, Banai, 
(2002) and Corbel, (1997). 
 Although the cross tabulation analysis findings obtained are not fitting 
to the objectives on the present study, nevertheless, they confirmed the 
superiority of cELISA over other conventional techniques in the diagnosis of 
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brucellosis. These outcomes are compatible with those reported previously in 
other studies (Lucero, 1999; Delpino et al., 2004; Al Attas et al., 2000).    
  The zoonotic nature of the disease besides its economic impact on both 
dairy and public health sectors, justifies mobilization of control programme. 
Under the Kuku circumstances, where the prevalence rate is 27.4%, eradication 
of the disease is impractical. According to Henk et al., (2004) the disease 
should be controlled by protection of free herds by vaccination, restriction of 
animals’ movement and culling of infected animals. In case of kuku scheme 
test and slaughter policy is not applicable in the presence of high prevalence 
rate and absence of compensation policy and the problem of obtaining 
Brucella free replacement animals. From producers point of view this policy is 
unaccepted. Only the owners of those herds with low prevalence rates (1%) 
support this policy. Segregation of infected animals or herds also is not 
applicable due to lack of extra fencing areas and the difficulty of management. 
Protection of free herds from Brucella infection by vaccinating exposed 
animals implies testing the whole population and isolation of free herds. In 
such circumstances of high prevalence rate and the difficulty in isolating free 
animals, testing all animal population is unjustifiable. However, 40% of the 
respondents support the policy of testing adult animals, isolation of positive 
reactors and vaccination of the negative ones (data not shown). Based on 
producer’s opinion, vaccination of the whole herd is the most suitable solution, 
which is supported by expert’s opinion, Figiri, (2005). Control policy coincide 
with extension efforts to raise awareness of the stockowners about the hazard 
of brucellosis is the only solution, Musa, (2004). It is worth mentioning that B. 
abortus strain 19 vaccine for cattle vaccination is available at low cost, 
Bakheit, (2004). The vaccine was proved efficient and safe, Figiri (2005). 
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Conclusions  
1. The endemicity of brucellosis in the Kuku Dairywas confirmed 
2. Cross-reaction with other organism does exist.  
3. The study identified the most suitable control strategy based on  producers 
and expert’s opinions. Yet simulation of different alternatives of the control 
strategy based on vaccine efficacy safety and hence cost benefit analysis of 
the control strategy was not an objective of the current study. 
4. The study proved that actively infected humans exist among in contact 
 population.         The number of infected humans will evolve if animal 
population kept constant without control strategy.  
5. Bottom up participatory approach including producers, consumers, workers 
and   researchers besides policy makers in case of zoonotic diseases control 
will act to strengthen the decision making and guarantee its implementation. 
6. Isolation of brucellae from milk distributed untreated to the general 
population represents a public health hazard for milk consumers. 
7. Although the knowledge of producers about zoonotic aspects of the disease 
is good, their work habits indicate the indifference to avoid infection.  
8. The susceptibility of brucellae to antibiotics in use is stable with few 
exceptions regarding Rifampicin.  
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Recommendations 
1. There is an urgent need to control of the animal disease in animals for 
economical and public health reasons and flourishment of dairy sector. 
2.  There is an urgent need to raise awareness of people at risk of 
brucellosis infection and its impact on man and animal so as to play a 
role in its control 
3. The study recommends further studies to understand the 
epidemiology of the disease. 
4. Strict measures are needed to ensure the safety of milk sold to the 
general population. 
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Appendix 1. Questionnaire sheet for bovine brucellosis survey in Kuku  
  Dairy  Co-operative Scheme, Khartoum North, Sudan, 2005.  
Date:…… ……………………….. Serial No.   …...………………………….. 
Farm   No.   ………………………………….….………………………… 
a. Personal data of the farm owner:  
Name of respondent:  ……………………………………………………….… 
Name (farm owner):……………… ………....………………………………… 
I. Occupation: ………….. II. Sex: …………………… …………….. 
II. Age:………………………………………………………………. 
IV. Marital Status: ……………….. ………………………………………… 
V. Ethnic origin: ………………………………..................... ……………… 
Address:………………………………..……………………………………… 
……………………….…………………………………………………………
…………………………………………………………………………………
………………   ……………….…………………………………………… 
b. Herd data: 
1. Number of animals raised:………………….2. Breed :……..……………. 
3. Breed source: ………………………………………………….................... 
4. Herd composition: 
Age  
 
Less than 
one year 
1-3 years More than 
 3 years   
Grand 
total 
Sex m F m f f m 
Number        
Sub-total       
Total     
 
   m= male; f= female 
c. Animal Health Data: 
1. How do you deal with sick animals? 
a. Have a recruited veterinarian or veterinary technician               
b. Call a veterinarian or veterinary technician  
c. Consult veterinary service center. 
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d. Treat them myself. 
2. Do you vaccinate your animals?   
    A. Yes                 b. No                        
3. If yes, what diseases you vaccinate your animals against? 
 …………………………………………………………………......................... 
 …………………………………………………………………………………. 
 ………………………………………………………………………………… 
 ………………………………………………………………………………… 
4. Do you have abortion cases in your farm? 
    a. Yes                               b. No 
5. If yes, how does it occur ? 
           a. Repeatedly        
           b. Sometimes 
6. Do you know the causes of it (i.e. abortion)? 
   Yes                    No                
7. if yes, what are they? 
 ………………………………………………………………………………  
…………….……………………………………………………………………  
……………………………………….………………………………………… 
8. What do you know about brucellosis? 
……………………………………….………..……………………………… 
……………………………………………………………….………………… 
…………………………………………………………………………….…… 
9. What are the symptoms of brucellosis? 
…………………………………………………………………………………
……………………………………………………………………………….…
………………………………………………………………………………… 
10. Do you vaccinate your animals against brucellosis? 
 Yes                             No      
11. How do you deal with animals that proved to have brucellosis? 
a. Sell them for slaughtering  
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b. Sell them to other farm (s) 
c. Treat them 
d. Leave them within the herd without treatment   
e.  Keep them in a separate place  
d. Herd management data: 
1. How do you keep your herd? 
a. Mixed                        b. Separated according to age  
c. Separated according to age and sex  
2. What type of breeding do you adopt?   
a. Natural insemination                    b. Artificial insemination  
3. In case of natural insemination, do you have your own bull {    } or borrow 
one  from other farms {     } 
4. How do you feed and water your animals? 
………………………………………………………………………………  
5.  What are the sources of food and water that you provide to your herd?  
…………………………………………………………………………………
……………………………………………………………………………… 
e. suggestions for control strategy: 
1. Are you aware of the economic significance of the disease with regard to 
production losses and negative impact in international trade  
a. Yes 
b. Rather yes 
c. No    
2. if the government initiate control programmes, do you support these 
programmes? 
 a. Yes 
 b Rather yes 
 c. No    
3. which of the following programmes do you support: 
a. vaccination of calves less than one year + test and slaughter of the positives 
adult reactors and vaccination of the negatives. 
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b. vaccination of calves less than one year + isolation of positive reactors and 
vaccination of the negative reactors 
d.   vaccination of calves less than one year + vaccination of the adults every 
two years for ten years then test and slaughter of the positive reactors 
4. are you willing to participate in the implementation of a such programmes? 
a. Yes 
b. no  
5. in what way will you contribute? 
a. shoulder vaccination cost 
b. shoulder testing cost 
c. isolation of the infected animals 
d. slaughter of the infected animals 
6. given the following average prices, which one do accept for your infected 
animal (as compensation)? 
a. SD 60 thousand  
b. SD 100 thousand 
c. SD 150 thousand 
d. SD 200 thousand 
e. SD 250 thousand 
f. SD 300 thousand 
g. SD 350 thousand  
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Appendix 2. Culture Medias' formulations.  
 The following culture media had been incorporated in the isolation and 
identification procedures for brucellae.  
1. Thayer Martin medium: -  
  Thayer martin medium contained haemoglobin, which provided the X 
factor (hemin), and GC enrichment, which provided the V factor, vitamins, 
amino acids, coenzymes and dextrose. The vancomycin in the formulation 
provided improve inhibition of gram-positive cocci. The addition of nystatin 
had proved to be effective in the suppression of Candida albicans. The medium 
also contained colistin as a selective agent to inhibit most gram-negative 
organisms, including Pseudomonas species.  
 Thayer Martin medium was made according to NAMRU-3, (2004). The 
following formula was used: 
2. GC medium                                                                         36gm 
3. distilled water                                                                      1000ml 
4. Haemoglobin Agar 2%                                                        10gm 
5. Iso-vitalex supplement                                                         10ml 
6. Vancomycin, Colistin and Nystatin  (V.C.N) supplement   20ml 
Preparation of the medium: 
1. 36gm GC media was suspended in 500ml-distilled water. 
2. The Agar was heated with constant stirring until dissolved completely. 
3. Autoclaved at 121 0C for 15 minutes. 
4. 10 gm of haemoglobin powder was added in 500 ml distilled water, 
heated with constant stirring until the haemoglobin dissolved 
completely. 
5. Autoclaved at 1210C for 15 minutes. 
6. Both GC media and haemoglobin were mixed into one flask 
immediately. 
7. The mixture was left to cool to 45-500C and 10ml of Iso-Vitalex and 20 
ml V.C.N supplement was added 
8. Stored at 40C until used. 
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2. Serum Dextrose Agar (SDA) 
 This medium was prepared as described by Alton et al (1975). The 
method was briefly as follows:  
To one litre of distilled water, the following quantities were added and the 
mixture was heated to dissolve. 
Agar     20grams 
Peptone    10g 
Sodium chloride   5g 
Meat extracts              5g 
The medium was sterilized by autoclaving at 1210C for 15 minutes and cooled 
to 560 C. Stock solution of serum dextrose prepared by adding 60 ml of 25% 
sterile dextrose to 50ml brucella negative horse inactivated serum (Inactivation 
done at 560C for 30 minutes) were added to the sterile medium at 560 C. Then 
the medium was poured in sterile Petri dishes and stored at 40C until used. 
3. Mueller Hinton Agar. 
 It was used to test the susceptibility of isolates to antibiotics in use. 
According to the manufacturer Himedia Laboratories, the following formula 
was used: 
 Standard formula: 
Casein acid hydrolysate    17.5 g 
Beef heart infusion    02.0 g 
Starch soluble    01.5g 
Agar      17.0 g 
Directions:  
 According to the manufacturer (Himedia Laboratories Pvt. Ltd. 23, 
Vadhani Ind.Est., LBs Marg, Mumbai-400 085, India):  
 38.0 g of the stock powder of Mueller Hinton Agar was suspended in 
1000ml-distilled water. Mixed well and heated to boiling to dissolve the 
medium completely. Sterilized by autoclaving at (1210C) for 15 minutes. 10% 
lysed horse blood was added at 560 C (i.e. the horse blood was lysed by 
freezing and thawing respectively several time, Miles and Amyes, (1996). The 
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medium was poured approximately to a depth of 4mm (25ml medium) in flat-
bottomed 9 cm Petri dishes in a level surface. The plates were stored at 4-80C 
until used. 
4. Christensen’s medium 
 This medium was constituted of urea agar base and urea solution. 
According to the manufacturer (International Diagnostic Group PLC. Topley 
House, 25 Wash Lane, Burg, Lancanshire Bla 6AU, UK. www.idgplc.com ) the 
following formula was used: 
(1) Urea agar                     g/L 
peptone       1.0 
glucose      1.0 
sodium chloride     5.0 
disodium phosphate         1.2 
potassium dihydrogen phosphate            0.8 
agar No.1      12.0 
phenol red      0.012 
(2) Urea solution: 
directions: 
 2.1 g of  above mentioned agar was weighed and dispersed in 95ml 
volume of distilled water, mixed, then sterilized by autoclaving at 1210C for 15 
minutes. Then was allowed to cool to 470C and 5ml of 40% sterile urea 
solution was added. The mixture was placed in slop position to make slant. The 
obtained slants were stored refrigerated at 4-80C until used. 
5. Tryptone Soy Broth: 
This media was used as a blood culture to test the sterility of patients blood 
suspected to have Brucellosis. According to (BIOTEC Laboratories Ltd., 38 
Anson Road, Martlesham Health, Ipswich, Suffok IP5 3RG, UK.) the 
following formula was used: 
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                                                                                         g/L 
Tryptone ( casein digest USP)                           17.0  
Soy peptone      03.0 
Sodium chloride     05.0 
Dipotassium phosphate    02.5 
Dextrose      02.5 
Directions: 
 30g of the above mentioned powder was dispersed in I litre of distilled 
water, mixed, heated to dissolved. Then dispensed in 50ml amount in 100ml 
volume, screw-capped medical bottles and autoclaved at 1210C for 15 minutes. 
The media was left to cool and stored at room temperature until used. The 
media was tested for contamination before use, by overnight incubation at 35-
370C. medium bottle that showed turbidity was discarded.  
 
